{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:50:26Z","timestamp":1792450226541,"version":"4.5.0"},"reference-count":296,"publisher":"Harborside Press, LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:p>Basal cell carcinoma (BCC) is the most common form of skin cancer in the United States. Due to the high frequency, BCC occurrences are not typically recorded, and annual rates of incidence can only be estimated. Current estimated rates are 2 million Americans affected annually, and this continues to rise. Exposure to radiation, from either sunlight or previous medical therapy, is a key player in BCC development. BCC is not as aggressive as other skin cancers because it is less likely to metastasize. However, surgery and radiation are prevalent treatment options, therefore disfigurement and limitation of function are significant considerations. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) outline an updated risk stratification and treatment options available for BCC.<\/jats:p>","DOI":"10.6004\/jnccn.2023.0056","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T15:31:49Z","timestamp":1699371109000},"page":"1181-1203","source":"Crossref","is-referenced-by-count":134,"title":["Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology"],"prefix":"10.6004","volume":"21","author":[{"given":"Chrysalyne D.","family":"Schmults","sequence":"first","affiliation":[{"name":"Dana-Farber\/Brigham and Women\u2019s Cancer Center | Mass General Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Blitzblau","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaira Z.","family":"Aasi","sequence":"additional","affiliation":[{"name":"Stanford Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murad","family":"Alam","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Amini","sequence":"additional","affiliation":[{"name":"City of Hope National Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Bibee","sequence":"additional","affiliation":[{"name":"The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Bordeaux","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center\/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ling","family":"Chen","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo M.","family":"Contreras","sequence":"additional","affiliation":[{"name":"The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick","family":"DiMaio","sequence":"additional","affiliation":[{"name":"Fred & Pamela Buffett Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Donigan","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute at the University of Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Farma","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Mayo Clinic Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Harms","sequence":"additional","affiliation":[{"name":"University of Michigan Rogel Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Ho","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Nicholas","family":"Lukens","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center at the University of Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Mark","sequence":"additional","affiliation":[{"name":"Indiana University Melvin and Bren Simon Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Medina","sequence":"additional","affiliation":[{"name":"University of Colorado Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishwer S.","family":"Nehal","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Nghiem","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Olino","sequence":"additional","affiliation":[{"name":"Yale Cancer Center\/Smilow Cancer Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo","family":"Park","sequence":"additional","affiliation":[{"name":"UC San Diego Moores Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejesh","family":"Patel","sequence":"additional","affiliation":[{"name":"University of Tennessee Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Puzanov","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Rich","sequence":"additional","affiliation":[{"name":"Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Sekulic","sequence":"additional","affiliation":[{"name":"Mayo Clinic Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok R.","family":"Shaha","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Srivastava","sequence":"additional","affiliation":[{"name":"UT Southwestern Simmons Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valencia","family":"Thomas","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Tomblinson","sequence":"additional","affiliation":[{"name":"Vanderbilt-Ingram Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Venkat","sequence":"additional","affiliation":[{"name":"UCLA Jonsson Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohui Gloria","family":"Xu","sequence":"additional","affiliation":[{"name":"University of Wisconsin Carbone Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegrid","family":"Yu","sequence":"additional","affiliation":[{"name":"UCSF Helen Diller Family Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Yusuf","sequence":"additional","affiliation":[{"name":"O\u2019Neal Comprehensive Cancer Center at UAB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"McCullough","sequence":"additional","affiliation":[{"name":"National Comprehensive Cancer Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Espinosa","sequence":"additional","affiliation":[{"name":"National Comprehensive Cancer Network"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"B1","series-title":"JAMA Dermatol","first-page":"976","article-title":"Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998\u20132012","volume":"151","author":"Asgari MM","year":"2015","unstructured":"Asgari MM, Moffet HH, Ray GT,  Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998\u20132012. JAMA Dermatol 2015;151:976\u2013981."},{"key":"B2","series-title":"CA Cancer J Clin","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel RL","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7\u201330."},{"key":"B3","series-title":"JAMA Dermatol","first-page":"1081","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012","volume":"151","author":"Rogers HW","year":"2015","unstructured":"Rogers HW, Weinstock MA, Feldman SR,  Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol 2015;151:1081\u20131086."},{"key":"B4","series-title":"J Cutan Med Surg","first-page":"166","article-title":"Trends in non-melanoma skin cancer (basal cell carcinoma and squamous cell carcinoma) in Canada: a descriptive analysis of available data","volume":"20","author":"Abbas M","year":"2016","unstructured":"Abbas M, Kalia S. Trends in non-melanoma skin cancer (basal cell carcinoma and squamous cell carcinoma) in Canada: a descriptive analysis of available data. J Cutan Med Surg 2016;20:166\u2013175."},{"key":"B5","series-title":"J Dtsch Dermatol Ges","first-page":"788","article-title":"Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010","volume":"13","author":"Rudolph C","year":"2015","unstructured":"Rudolph C, Schnoor M, Eisemann N,  Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010. J Dtsch Dermatol Ges 2015;13:788\u2013797."},{"key":"B6","series-title":"Mayo Clin Proc","first-page":"890","article-title":"Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010","volume":"92","author":"Muzic JG","year":"2017","unstructured":"Muzic JG, Schmitt AR, Wright AC,  Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010. Mayo Clin Proc 2017;92:890\u2013898."},{"key":"B7","series-title":"JAMA","first-page":"681","article-title":"Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years","volume":"294","author":"Christenson LJ","year":"2005","unstructured":"Christenson LJ, Borrowman TA, Vachon CM,  Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005;294:681\u2013690."},{"key":"B8","series-title":"J Am Acad Dermatol","first-page":"1043","article-title":"Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature","volume":"10","author":"von Domarus H","year":"1984","unstructured":"von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 1984;10:1043\u20131060."},{"key":"B9","series-title":"Eur J Dermatol","first-page":"463","article-title":"The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997\u20132010","volume":"25","author":"Nguyen-Nielsen M","year":"2015","unstructured":"Nguyen-Nielsen M, Wang L, Pedersen L,  The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997\u20132010. Eur J Dermatol 2015;25:463\u2013468."},{"key":"B10","series-title":"Dermatol Online J","first-page":"7","article-title":"Metastatic basal cell carcinoma: a case report and literature review. How accurate is our incidence data?","volume":"12","author":"Wadhera A","year":"2006","unstructured":"Wadhera A, Fazio M, Bricca G,  Metastatic basal cell carcinoma: a case report and literature review. How accurate is our incidence data? Dermatol Online J 2006;12:7."},{"key":"B11","series-title":"Int J Cancer","first-page":"489","article-title":"Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia","volume":"60","author":"Kricker A","year":"1995","unstructured":"Kricker A, Armstrong BK, English DR,  Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer 1995;60:489\u2013494."},{"key":"B12","series-title":"Int J Cancer","first-page":"482","article-title":"A dose-response curve for sun exposure and basal cell carcinoma","volume":"60","author":"Kricker A","year":"1995","unstructured":"Kricker A, Armstrong BK, English DR,  A dose-response curve for sun exposure and basal cell carcinoma. Int J Cancer 1995;60:482\u2013488."},{"key":"B13","series-title":"Br J Cancer","first-page":"743","article-title":"Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case- control study","volume":"94","author":"Zanetti R","year":"2006","unstructured":"Zanetti R, Rosso S, Martinez C,  Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case- control study. Br J Cancer 2006;94:743\u2013751."},{"key":"B14","series-title":"Arch Dermatol","first-page":"157","article-title":"Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma","volume":"131","author":"Gallagher RP","year":"1995","unstructured":"Gallagher RP, Hill GB, Bajdik CD,  Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995;131:157\u2013163."},{"key":"B15","series-title":"J Am Acad Dermatol","first-page":"397","article-title":"Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia","volume":"49","author":"Ramsay HM","year":"2003","unstructured":"Ramsay HM, Fryer AA, Hawley CM,  Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003;49:397\u2013406."},{"key":"B16","series-title":"J Eur Acad Dermatol Venereol","first-page":"134","article-title":"Ultraviolet exposure and risk of melanoma and basal cell carcinoma in Ulm and Dresden, Germany","volume":"29","author":"Kaskel P","year":"2015","unstructured":"Kaskel P, Lange U, Sander S,  Ultraviolet exposure and risk of melanoma and basal cell carcinoma in Ulm and Dresden, Germany. J Eur Acad Dermatol Venereol 2015;29:134\u2013142."},{"key":"B17","series-title":"Cancer Epidemiol","first-page":"534","article-title":"A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin","volume":"37","author":"Khalesi M","year":"2013","unstructured":"Khalesi M, Whiteman DC, Tran B,  A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin. Cancer Epidemiol 2013;37:534\u2013543."},{"key":"B18","series-title":"Br J Dermatol","first-page":"170","article-title":"Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor","volume":"151","author":"Walther U","year":"2004","unstructured":"Walther U, Kron M, Sander S,  Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol 2004;151:170\u2013178."},{"key":"B19","series-title":"J Invest Dermatol","first-page":"224","article-title":"Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma","volume":"116","author":"Box NF","year":"2001","unstructured":"Box NF, Duffy DL, Irving RE,  Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 2001;116:224\u2013229."},{"key":"B20","series-title":"Acta Derm Venereol","first-page":"74","article-title":"Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma. A Danish case-control study","volume":"79","author":"Lock-Andersen J","year":"1999","unstructured":"Lock-Andersen J, Drzewiecki KT, Wulf HC. Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma. A Danish case-control study. Acta Derm Venereol 1999;79:74\u201380."},{"key":"B21","series-title":"Rev Assoc Med Bras (1992)","first-page":"188","article-title":"Prevalence of actinic skin lesions in patients with basal cell carcinoma of the head: a case-control study","volume":"58","author":"Chinem VP","year":"2012","unstructured":"Chinem VP, Miot HA. Prevalence of actinic skin lesions in patients with basal cell carcinoma of the head: a case-control study. Rev Assoc Med Bras (1992) 2012;58:188\u2013196."},{"key":"B22","series-title":"Am J Epidemiol","first-page":"890","article-title":"Basal-cell carcinoma incidence and associated risk factors in U.S. women and men","volume":"178","author":"Wu S","year":"2013","unstructured":"Wu S, Han J, Li WQ,  Basal-cell carcinoma incidence and associated risk factors in U.S. women and men. Am J Epidemiol 2013;178:890\u2013897."},{"key":"B23","series-title":"J Clin Oncol","first-page":"3733","article-title":"Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study","volume":"23","author":"Perkins JL","year":"2005","unstructured":"Perkins JL, Liu Y, Mitby PA,  Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol 2005;23:3733\u20133741."},{"key":"B24","series-title":"Epidemiology","first-page":"776","article-title":"Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure","volume":"18","author":"Karagas MR","year":"2007","unstructured":"Karagas MR, Nelson HH, Zens MS,  Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure. Epidemiology 2007;18:776\u2013784."},{"key":"B25","series-title":"J Natl Cancer Inst","first-page":"1240","article-title":"Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study","volume":"104","author":"Watt TC","year":"2012","unstructured":"Watt TC, Inskip PD, Stratton K,  Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2012;104:1240\u20131250."},{"key":"B26","series-title":"Radiat Res","first-page":"155","article-title":"Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation","volume":"171","author":"Schwartz JL","year":"2009","unstructured":"Schwartz JL, Kopecky KJ, Mathes RW,  Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation. Radiat Res 2009;171:155\u2013163."},{"key":"B27","series-title":"J Natl Cancer Inst","first-page":"1848","article-title":"Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy","volume":"88","author":"Karagas MR","year":"1996","unstructured":"Karagas MR, McDonald JA, Greenberg ER,  Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. J Natl Cancer Inst 1996;88:1848\u20131853."},{"key":"B28","article-title":"PubMed overview","unstructured":"National Institutes of Health. PubMed overview. Accessed September 1, 2023. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/about\/"},{"key":"B29","series-title":"J Natl Compr Canc Netw","first-page":"434","article-title":"The value and process of inclusion: using sensitive, respectful, and inclusive language and images in NCCN content","volume":"21","author":"Freedman-Cass DA","year":"2023","unstructured":"Freedman-Cass DA, Fischer T, Alpert AB,  The value and process of inclusion: using sensitive, respectful, and inclusive language and images in NCCN content. J Natl Compr Canc Netw 2023;21:434\u2013441."},{"key":"B30","series-title":"Arch Dermatol Res","first-page":"39","article-title":"Relation between sonic hedgehog pathway gene polymorphisms and basal cell carcinoma development in the Polish population","volume":"308","author":"Lesiak A","year":"2016","unstructured":"Lesiak A, Sobolewska-Sztychny D, Majak P,  Relation between sonic hedgehog pathway gene polymorphisms and basal cell carcinoma development in the Polish population. Arch Dermatol Res 2016;308:39\u201347."},{"key":"B31","series-title":"Cancer Res","first-page":"1798","article-title":"Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system","volume":"58","author":"Reifenberger J","year":"1998","unstructured":"Reifenberger J, Wolter M, Weber RG,  Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1998;58:1798\u20131803."},{"key":"B32","series-title":"Nature","first-page":"90","article-title":"Activating smoothened mutations in sporadic basal-cell carcinoma","volume":"391","author":"Xie J","year":"1998","unstructured":"Xie J, Murone M, Luoh SM,  Activating smoothened mutations in sporadic basal-cell carcinoma. Nature 1998;391:90\u201392."},{"key":"B33","series-title":"Cell","first-page":"111","article-title":"Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9","volume":"69","author":"Gailani MR","year":"1992","unstructured":"Gailani MR, Bale SJ, Leffell DJ,  Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 1992;69:111\u2013117."},{"key":"B34","series-title":"Br J Cancer","first-page":"548","article-title":"PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study","volume":"95","author":"Soufir N","year":"2006","unstructured":"Soufir N, Gerard B, Portela M,  PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study. Br J Cancer 2006;95:548\u2013553."},{"key":"B35","series-title":"Oncogene","first-page":"7770","article-title":"PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer","volume":"20","author":"Ling G","year":"2001","unstructured":"Ling G, Ahmadian A, Persson A,  PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer. Oncogene 2001;20:7770\u20137778."},{"key":"B36","series-title":"J Invest Dermatol","first-page":"2872","article-title":"UV fingerprints predominate in the PTCH mutation spectra of basal cell carcinomas independent of clinical phenotype","volume":"127","author":"Heitzer E","year":"2007","unstructured":"Heitzer E, Lassacher A, Quehenberger F,  UV fingerprints predominate in the PTCH mutation spectra of basal cell carcinomas independent of clinical phenotype. J Invest Dermatol 2007;127:2872\u20132881."},{"key":"B37","series-title":"J Invest Dermatol","first-page":"1152","article-title":"Allelic loss at Drosophila patched gene is highly prevalent in basal and squamous cell carcinomas of the skin","volume":"126","author":"Danaee H","year":"2006","unstructured":"Danaee H, Karagas MR, Kelsey KT,  Allelic loss at Drosophila patched gene is highly prevalent in basal and squamous cell carcinomas of the skin. J Invest Dermatol 2006;126:1152\u20131158."},{"key":"B38","series-title":"Br J Dermatol","first-page":"43","article-title":"Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas","volume":"152","author":"Reifenberger J","year":"2005","unstructured":"Reifenberger J, Wolter M, Knobbe CB,  Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 2005;152:43\u201351."},{"key":"B39","series-title":"J Dermatol Sci","first-page":"1","article-title":"Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias","volume":"29","author":"Kim MY","year":"2002","unstructured":"Kim MY, Park HJ, Baek SC,  Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias. J Dermatol Sci 2002;29:1\u20139."},{"key":"B40","series-title":"Nat Genet","first-page":"78","article-title":"The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas","volume":"14","author":"Gailani MR","year":"1996","unstructured":"Gailani MR, St\u00e5hle-B\u00e4ckdahl M, Leffell DJ,  The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 1996;14:78\u201381."},{"key":"B41","series-title":"Am J Pathol","first-page":"381","article-title":"Role of PTCH and p53 genes in early-onset basal cell carcinoma","volume":"158","author":"Zhang H","year":"2001","unstructured":"Zhang H, Ping XL, Lee PK,  Role of PTCH and p53 genes in early-onset basal cell carcinoma. Am J Pathol 2001;158:381\u2013385."},{"key":"B42","series-title":"Proc Natl Acad Sci USA","first-page":"4216","article-title":"Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers","volume":"90","author":"Ziegler A","year":"1993","unstructured":"Ziegler A, Leffell DJ, Kunala S,  Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 1993;90:4216\u20134220."},{"key":"B43","series-title":"Br J Cancer","first-page":"714","article-title":"Superficial cancer in Nigeria","volume":"23","author":"Oluwasanmi JO","year":"1969","unstructured":"Oluwasanmi JO, Williams AO, Alli AF. Superficial cancer in Nigeria. Br J Cancer 1969;23:714\u2013728."},{"key":"B44","series-title":"Trop Doct","first-page":"63","article-title":"Skin cancer in Zaria, Nigeria","volume":"25","author":"Yakubu A","year":"1995","unstructured":"Yakubu A, Mabogunje OA. Skin cancer in Zaria, Nigeria. Trop Doct 1995;25(Suppl 1):63\u201367."},{"key":"B45","series-title":"Arch Dermatol","first-page":"241","article-title":"Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases","volume":"123","author":"Kraemer KH","year":"1987","unstructured":"Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987;123:241\u2013250."},{"key":"B46","series-title":"J Med Genet","first-page":"168","article-title":"Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair","volume":"48","author":"Bradford PT","year":"2011","unstructured":"Bradford PT, Goldstein AM, Tamura D,  Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet 2011;48:168\u2013176."},{"key":"B47","series-title":"Arch Dermatol","first-page":"1018","article-title":"The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm","volume":"130","author":"Kraemer KH","year":"1994","unstructured":"Kraemer KH, Lee MM, Andrews AD,  The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 1994;130:1018\u20131021."},{"key":"B48","series-title":"Carcinogenesis","first-page":"511","article-title":"DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum","volume":"5","author":"Kraemer KH","year":"1984","unstructured":"Kraemer KH, Lee MM, Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 1984;5:511\u2013514."},{"key":"B49","series-title":"Cancer Res","first-page":"3559","article-title":"Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients","volume":"64","author":"Couv\u00e9-Privat S","year":"2004","unstructured":"Couv\u00e9-Privat S, Le Bret M, Traiffort E,  Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients. Cancer Res 2004;64:3559\u20133565."},{"key":"B50","series-title":"Cancer Res","first-page":"7186","article-title":"Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients","volume":"62","author":"Couv\u00e9-Privat S","year":"2002","unstructured":"Couv\u00e9-Privat S, Bouadjar B, Avril MF,  Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer Res 2002;62:7186\u20137189."},{"key":"B51","series-title":"Carcinogenesis","first-page":"1670","article-title":"XPA, haplotypes, and risk of basal and squamous cell carcinoma","volume":"27","author":"Miller KL","year":"2006","unstructured":"Miller KL, Karagas MR, Kraft P,  XPA, haplotypes, and risk of basal and squamous cell carcinoma. Carcinogenesis 2006;27:1670\u20131675."},{"key":"B52","series-title":"Arch Dermatol Res","first-page":"319","article-title":"Upstaging of basal cell and squamous cell carcinomas during definitive surgery: a review of predictive preoperative clinical and histologic features","volume":"313","author":"Clements S","year":"2021","unstructured":"Clements S, Khachemoune A. Upstaging of basal cell and squamous cell carcinomas during definitive surgery: a review of predictive preoperative clinical and histologic features. Arch Dermatol Res 2021;313:319\u2013325."},{"key":"B53","series-title":"Dermatol Surg","first-page":"1003","article-title":"Detection of high-risk histologic features and tumor upstaging of nonmelanoma skin cancers on debulk analysis: a quantitative systematic review","volume":"43","author":"Singh B","year":"2017","unstructured":"Singh B, Dorelles A, Konnikov N,  Detection of high-risk histologic features and tumor upstaging of nonmelanoma skin cancers on debulk analysis: a quantitative systematic review. Dermatol Surg 2017;43:1003\u20131011."},{"key":"B54","series-title":"J Natl Cancer Inst","first-page":"1215","article-title":"Nonmelanoma skin cancer and risk for subsequent malignancy","volume":"100","author":"Chen J","year":"2008","unstructured":"Chen J, Ruczinski I, Jorgensen TJ,  Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 2008;100:1215\u20131222."},{"key":"B55","series-title":"J Am Acad Dermatol","first-page":"582","article-title":"Brigham and Women\u2019s Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death","volume":"85","author":"Morgan FC","year":"2021","unstructured":"Morgan FC, Ruiz ES, Karia PS,  Brigham and Women\u2019s Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death. J Am Acad Dermatol 2021;85:582\u2013587."},{"key":"B56","series-title":"Head Neck","first-page":"469","article-title":"Detecting and defining the anatomic extent of large nerve perineural spread of malignancy: comparing \u201ctargeted\u201d MRI with the histologic findings following surgery","volume":"33","author":"Gandhi MR","year":"2011","unstructured":"Gandhi MR, Panizza B, Kennedy D. Detecting and defining the anatomic extent of large nerve perineural spread of malignancy: comparing \u201ctargeted\u201d MRI with the histologic findings following surgery. Head Neck 2011;33:469\u2013475."},{"key":"B57","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1061","article-title":"Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis","volume":"49","author":"Williams LS","year":"2001","unstructured":"Williams LS, Mancuso AA, Mendenhall WM. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int J Radiat Oncol Biol Phys 2001;49:1061\u20131069."},{"key":"B58","series-title":"Cutaneous Oncology: Pathophysiology, Diagnosis, and Management","first-page":"646","article-title":"Features associated with recurrence (basal cell carcinoma)","author":"Boeta-Angeles","year":"1998","unstructured":"Boeta-Angeles, Bennett RG. Features associated with recurrence (basal cell carcinoma). In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Blackwell Science; 1998:pp. 646\u2013656."},{"key":"B59","series-title":"J Dermatol Surg Oncol","first-page":"471","article-title":"Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision","volume":"18","author":"Silverman MK","year":"1992","unstructured":"Silverman MK, Kopf AW, Bart RS,  Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision. J Dermatol Surg Oncol 1992;18:471\u2013476."},{"key":"B60","series-title":"J Dermatol Surg Oncol","first-page":"720","article-title":"Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodesiccation","volume":"17","author":"Silverman MK","year":"1991","unstructured":"Silverman MK, Kopf AW, Grin CM,  Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodesiccation. J Dermatol Surg Oncol 1991;17:720\u2013726."},{"key":"B61","series-title":"Arch Dermatol","first-page":"373","article-title":"Multivariate risk score for recurrence of cutaneous basal cell carcinomas","volume":"119","author":"Dubin N","year":"1983","unstructured":"Dubin N, Kopf AW. Multivariate risk score for recurrence of cutaneous basal cell carcinomas. Arch Dermatol 1983;119:373\u2013377."},{"key":"B62","series-title":"Acta Derm Venereol","first-page":"330","article-title":"Factors affecting the recurrence rate of basal cell carcinoma","volume":"87","author":"B\u00f8gelund FS","year":"2007","unstructured":"B\u00f8gelund FS, Philipsen PA, Gniadecki R. Factors affecting the recurrence rate of basal cell carcinoma. Acta Derm Venereol 2007;87:330\u2013334."},{"key":"B63","series-title":"J Dermatol Surg Oncol","first-page":"807","article-title":"Predicting recurrence of basal-cell carcinomas treated by microscopically controlled excision: a recurrence index score","volume":"7","author":"Rigel DS","year":"1981","unstructured":"Rigel DS, Robins P, Friedman RJ. Predicting recurrence of basal-cell carcinomas treated by microscopically controlled excision: a recurrence index score. J Dermatol Surg Oncol 1981;7:807\u2013810."},{"key":"B64","series-title":"J Am Acad Dermatol","first-page":"808","article-title":"Treatment of basal cell epithelioma by curettage and electrodesiccation","volume":"11","author":"Spiller WF","year":"1984","unstructured":"Spiller WF, Spiller RF. Treatment of basal cell epithelioma by curettage and electrodesiccation. J Am Acad Dermatol 1984;11:808\u2013814."},{"key":"B65","series-title":"Br J Dermatol","first-page":"1078","article-title":"Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up","volume":"153","author":"van Iersel CA","year":"2005","unstructured":"van Iersel CA, van de Velden HV, Kusters CD,  Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up. Br J Dermatol 2005;153:1078\u20131080."},{"key":"B66","series-title":"Am J Surg","first-page":"447","article-title":"Treatment results and patterns of failure in 646 patients with carcinoma of the eyelids, pinna, and nose","volume":"154","author":"Petrovich Z","year":"1987","unstructured":"Petrovich Z, Kuisk H, Langholz B,  Treatment results and patterns of failure in 646 patients with carcinoma of the eyelids, pinna, and nose. Am J Surg 1987;154:447\u2013450."},{"key":"B67","series-title":"J Dermatol Surg Oncol","first-page":"713","article-title":"Recurrence rates of treated basal cell carcinomas. Part 1: overview","volume":"17","author":"Silverman MK","year":"1991","unstructured":"Silverman MK, Kopf AW, Grin CM,  Recurrence rates of treated basal cell carcinomas. Part 1: overview. J Dermatol Surg Oncol 1991;17:713\u2013718."},{"key":"B68","series-title":"Dermatol Surg","first-page":"1582","article-title":"AAD\/ACMS\/ASDSA\/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery","volume":"38","author":"Connolly SM","year":"2012","unstructured":"Connolly SM, Baker DR, Coldiron BM,  AAD\/ACMS\/ASDSA\/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. Dermatol Surg 2012;38:1582\u20131603."},{"key":"B69","series-title":"J Cutan Pathol","first-page":"137","article-title":"Histologic features predictive of basal cell carcinoma recurrence: results of a multivariate analysis","volume":"20","author":"Dixon AY","year":"1993","unstructured":"Dixon AY, Lee SH, McGregor DH. Histologic features predictive of basal cell carcinoma recurrence: results of a multivariate analysis. J Cutan Pathol 1993;20:137\u2013142."},{"key":"B70","series-title":"Cancer","first-page":"533","article-title":"Prediction of aggressive behavior in basal cell carcinoma","volume":"49","author":"Jacobs GH","year":"1982","unstructured":"Jacobs GH, Rippey JJ, Altini M. Prediction of aggressive behavior in basal cell carcinoma. Cancer 1982;49:533\u2013537."},{"key":"B71","series-title":"Cancer","first-page":"544","article-title":"Comparative morphometric analysis of aggressive and ordinary basal cell carcinoma of the skin","volume":"65","author":"de Rosa G","year":"1990","unstructured":"de Rosa G, Vetrani A, Zeppa P,  Comparative morphometric analysis of aggressive and ordinary basal cell carcinoma of the skin. Cancer 1990;65:544\u2013549."},{"key":"B72","series-title":"J Plast Surg Hand Surg","first-page":"38","article-title":"Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management","volume":"48","author":"Codazzi D","year":"2014","unstructured":"Codazzi D, Van Der Velden J, Carminati M,  Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management. J Plast Surg Hand Surg 2014;48:38\u201343."},{"key":"B73","series-title":"Br J Dermatol","first-page":"95","article-title":"Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study","volume":"174","author":"Krynitz B","year":"2016","unstructured":"Krynitz B, Olsson H, Lundh Rozell B,  Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study. Br J Dermatol 2016;174:95\u2013103."},{"key":"B74","series-title":"Br J Dermatol","first-page":"1047","article-title":"Skin tumours in the West of Scotland renal transplant population","volume":"168","author":"Mackintosh LJ","year":"2013","unstructured":"Mackintosh LJ, Geddes CC, Herd RM. Skin tumours in the West of Scotland renal transplant population. Br J Dermatol 2013;168:1047\u20131053."},{"key":"B75","series-title":"Acta Derm Venereol","first-page":"422","article-title":"Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region","volume":"93","author":"Bernat Garc\u00eda J","year":"2013","unstructured":"Bernat Garc\u00eda J, Morales Su\u00e1rez-Varela M, Vilata JJ,  Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region. Acta Derm Venereol 2013;93:422\u2013427."},{"key":"B76","series-title":"Transplant Proc","first-page":"3760","article-title":"Skin cancer following kidney transplantation: a single-center experience","volume":"43","author":"Karczewski M","year":"2011","unstructured":"Karczewski M, Stronka M, Karczewski J,  Skin cancer following kidney transplantation: a single-center experience. Transplant Proc 2011;43:3760\u20133761."},{"key":"B77","series-title":"Transplantation","first-page":"574","article-title":"Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate","volume":"77","author":"Bordea C","year":"2004","unstructured":"Bordea C, Wojnarowska F, Millard PR,  Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004;77:574\u2013579."},{"key":"B78","series-title":"JAMA Dermatol","first-page":"775","article-title":"Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review","volume":"151","author":"DePry JL","year":"2015","unstructured":"DePry JL, Vyas R, Lazarus HM,  Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review. JAMA Dermatol 2015;151:775\u2013782."},{"key":"B79","series-title":"J Natl Cancer Inst","first-page":"1278","article-title":"Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA follow-up study","volume":"90","author":"Stern RS","year":"1998","unstructured":"Stern RS, Liebman EJ, V\u00e4kev\u00e4 L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA follow-up study. J Natl Cancer Inst 1998;90:1278\u20131284."},{"key":"B80","series-title":"J Eur Acad Dermatol Venereol","first-page":"22","article-title":"Carcinogenic risks of psoralen ultraviolet-A therapy and narrowband ultraviolet-B therapy in chronic plaque psoriasis: a systematic literature review","volume":"26","author":"Archier E","year":"2012","unstructured":"Archier E, Devaux S, Castela E,  Carcinogenic risks of psoralen ultraviolet-A therapy and narrowband ultraviolet-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012;26(Suppl 3):22\u201331."},{"key":"B81","series-title":"J Am Acad Dermatol","first-page":"465","article-title":"Incidence of primary skin cancer after organ transplantation: an 18-year single-center experience in Korea","volume":"70","author":"Park GH","year":"2014","unstructured":"Park GH, Chang SE, Won CH,  Incidence of primary skin cancer after organ transplantation: an 18-year single-center experience in Korea. J Am Acad Dermatol 2014;70:465\u2013472."},{"key":"B82","series-title":"Acta Derm Venereol","first-page":"474","article-title":"Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark","volume":"90","author":"Jensen AO","year":"2010","unstructured":"Jensen AO, Svaerke C, Farkas D,  Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Acta Derm Venereol 2010;90:474\u2013479."},{"key":"B83","series-title":"Transplantation","first-page":"506","article-title":"Incidence of skin cancer after renal transplantation in The Netherlands","volume":"49","author":"Hartevelt MM","year":"1990","unstructured":"Hartevelt MM, Bavinck JN, Kootte AM,  Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990;49:506\u2013509."},{"key":"B84","series-title":"Am J Transplant","first-page":"119","article-title":"A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population","volume":"13","author":"Harwood CA","year":"2013","unstructured":"Harwood CA, Mesher D, McGregor JM,  A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population. Am J Transplant 2013;13:119\u2013129."},{"key":"B85","series-title":"Arch Dermatol","first-page":"1391","article-title":"Incidence of and risk factors for skin cancer after heart transplant","volume":"145","author":"Brewer JD","year":"2009","unstructured":"Brewer JD, Colegio OR, Phillips PK,  Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol 2009;145:1391\u20131396."},{"key":"B86","series-title":"J Am Acad Dermatol","first-page":"92","article-title":"Incidence and risk factors for skin cancer following lung transplantation","volume":"72","author":"Rashtak S","year":"2015","unstructured":"Rashtak S, Dierkhising RA, Kremers WK,  Incidence and risk factors for skin cancer following lung transplantation. J Am Acad Dermatol 2015;72:92\u201398."},{"key":"B87","series-title":"Arch Dermatol","first-page":"1079","article-title":"Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients","volume":"140","author":"Fortina AB","year":"2004","unstructured":"Fortina AB, Piaserico S, Caforio AL,  Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004;140:1079\u20131085."},{"key":"B88","series-title":"Arch Dermatol","first-page":"1133","article-title":"Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases","volume":"139","author":"Kanitakis J","year":"2003","unstructured":"Kanitakis J, Alhaj-Ibrahim L, Euvrard S,  Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases. Arch Dermatol 2003;139:1133\u20131137."},{"key":"B89","series-title":"J Am Acad Dermatol","first-page":"290","article-title":"Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series","volume":"54","author":"Harwood CA","year":"2006","unstructured":"Harwood CA, Proby CM, McGregor JM,  Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006;54:290\u2013300."},{"key":"B90","series-title":"Transplantation","first-page":"683","article-title":"Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients","volume":"90","author":"Lott DG","year":"2010","unstructured":"Lott DG, Manz R, Koch C,  Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients. Transplantation 2010;90:683\u2013687."},{"key":"B91","series-title":"Cancer","first-page":"61","article-title":"Radiation-induced skin cancer of the head and neck","volume":"25","author":"Martin H","year":"1970","unstructured":"Martin H, Strong E, Spiro RH. Radiation-induced skin cancer of the head and neck. Cancer 1970;25:61\u201371."},{"key":"B92","series-title":"Arch Dermatol","first-page":"1007","article-title":"Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma","volume":"136","author":"Lichter MD","year":"2000","unstructured":"Lichter MD, Karagas MR, Mott LA,  Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. Arch Dermatol 2000;136:1007\u20131011."},{"key":"B93","series-title":"Am J Dermatopathol","first-page":"222","article-title":"Factors predictive of recurrence of basal cell carcinoma","volume":"11","author":"Dixon AY","year":"1989","unstructured":"Dixon AY, Lee SH, McGregor DH. Factors predictive of recurrence of basal cell carcinoma. Am J Dermatopathol 1989;11:222\u2013232."},{"key":"B94","series-title":"Br J Dermatol","first-page":"141","article-title":"Mohs\u2019 micrographic surgery for treatment of basal cell carcinoma of the face\u2014results of a retrospective study and review of the literature","volume":"151","author":"Smeets NW","year":"2004","unstructured":"Smeets NW, Kuijpers DI, Nelemans P,  Mohs\u2019 micrographic surgery for treatment of basal cell carcinoma of the face\u2014results of a retrospective study and review of the literature. Br J Dermatol 2004;151:141\u2013147."},{"key":"B95","series-title":"J Skin Cancer","first-page":"476362","article-title":"Basal cell carcinoma: 10 years of experience","volume":"2011","author":"Cigna E","year":"2011","unstructured":"Cigna E, Tarallo M, Maruccia M,  Basal cell carcinoma: 10 years of experience. J Skin Cancer 2011;2011:476362."},{"key":"B96","series-title":"Postepy Dermatol Alergol","first-page":"146","article-title":"Analysis of selected recurrence risk factors after treatment of head and neck basal cell carcinoma","volume":"31","author":"Szewczyk MP","year":"2014","unstructured":"Szewczyk MP, Pazdrowski J, Da\u0144czak-Pazdrowska A,  Analysis of selected recurrence risk factors after treatment of head and neck basal cell carcinoma. Postepy Dermatol Alergol 2014;31:146\u2013151."},{"key":"B97","series-title":"Acta Dermatovenerol Alp Panonica Adriat","first-page":"67","article-title":"Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions","volume":"20","author":"Barto\u0161 V","year":"2011","unstructured":"Barto\u0161 V, Pokorn\u00fd D, Zacharov\u00e1 O,  Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions. Acta Dermatovenerol Alp Panonica Adriat 2011;20:67\u201375."},{"key":"B98","series-title":"Oncol Rep","first-page":"1423","article-title":"Facial basal cell carcinoma: analysis of recurrence and follow-up strategies","volume":"26","author":"Sartore L","year":"2011","unstructured":"Sartore L, Lancerotto L, Salmaso M,  Facial basal cell carcinoma: analysis of recurrence and follow-up strategies. Oncol Rep 2011;26:1423\u20131429."},{"key":"B99","series-title":"Br J Dermatol","first-page":"127","article-title":"The value of typing basal cell carcinomas in predicting recurrence after surgical excision","volume":"96","author":"Sloane JP","year":"1977","unstructured":"Sloane JP. The value of typing basal cell carcinomas in predicting recurrence after surgical excision. Br J Dermatol 1977;96:127\u2013132."},{"key":"B100","series-title":"J Plast Reconstr Aesthet Surg","first-page":"424","article-title":"Basosquamous carcinoma-an under-recognized, high-risk cutaneous neoplasm: case study and review of the literature","volume":"59","author":"Costantino D","year":"2006","unstructured":"Costantino D, Lowe L, Brown DL. Basosquamous carcinoma-an under-recognized, high-risk cutaneous neoplasm: case study and review of the literature. J Plast Reconstr Aesthet Surg 2006;59:424\u2013428."},{"key":"B101","series-title":"Cancer","first-page":"1365","article-title":"Basosquamous carcinoma: analysis of prognostic factors influencing recurrence","volume":"88","author":"Martin RC 2nd","year":"2000","unstructured":"Martin RC 2nd, Edwards MJ, Cawte TG,  Basosquamous carcinoma: analysis of prognostic factors influencing recurrence. Cancer 2000;88:1365\u20131369."},{"key":"B102","series-title":"J Am Acad Dermatol","first-page":"137","article-title":"Basosquamous carcinoma","volume":"60","author":"Garcia C","year":"2009","unstructured":"Garcia C, Poletti E, Crowson AN. Basosquamous carcinoma. J Am Acad Dermatol 2009;60:137\u2013143."},{"key":"B103","series-title":"Neoplasia","first-page":"301","article-title":"Basosquamous carcinoma of the head and neck: clinical and histologic characteristics and their impact on disease progression","volume":"17","author":"Wermker K","year":"2015","unstructured":"Wermker K, Roknic N, Goessling K,  Basosquamous carcinoma of the head and neck: clinical and histologic characteristics and their impact on disease progression. Neoplasia 2015;17:301\u2013305."},{"key":"B104","series-title":"Dermatol Surg","first-page":"1101","article-title":"Peritumoral fibrosis in basal cell and squamous cell carcinoma mimicking perineural invasion: potential pitfall in Mohs micrographic surgery","volume":"31","author":"Hassanein AM","year":"2005","unstructured":"Hassanein AM, Proper SA, Depcik-Smith ND,  Peritumoral fibrosis in basal cell and squamous cell carcinoma mimicking perineural invasion: potential pitfall in Mohs micrographic surgery. Dermatol Surg 2005;31:1101\u20131106."},{"key":"B105","series-title":"Int J Radiat Oncol Biol Phys","first-page":"334","article-title":"Perineural infiltration of cutaneous squamous cell carcinoma and basal cell carcinoma without clinical features","volume":"82","author":"Lin C","year":"2012","unstructured":"Lin C, Tripcony L, Keller J,  Perineural infiltration of cutaneous squamous cell carcinoma and basal cell carcinoma without clinical features. Int J Radiat Oncol Biol Phys 2012;82:334\u2013340."},{"key":"B106","series-title":"Head Neck","first-page":"1027","article-title":"Carcinoma of the skin with perineural invasion","volume":"25","author":"Garcia-Serra A","year":"2003","unstructured":"Garcia-Serra A, Hinerman RW, Mendenhall WM,  Carcinoma of the skin with perineural invasion. Head Neck 2003;25:1027\u20131033."},{"key":"B107","series-title":"Clin Oncol (R Coll Radiol)","first-page":"362","article-title":"Cutaneous carcinoma of the head and neck with clinical features of perineural infiltration treated with radiotherapy","volume":"25","author":"Lin C","year":"2013","unstructured":"Lin C, Tripcony L, Keller J,  Cutaneous carcinoma of the head and neck with clinical features of perineural infiltration treated with radiotherapy. Clin Oncol (R Coll Radiol) 2013;25:362\u2013367."},{"key":"B108","series-title":"J Am Acad Dermatol","first-page":"458","article-title":"Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion","volume":"53","author":"Leibovitch I","year":"2005","unstructured":"Leibovitch I, Huilgol SC, Selva D,  Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. J Am Acad Dermatol 2005;53:458\u2013463."},{"key":"B109","series-title":"Head Neck","first-page":"604","article-title":"Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: toward a risk-adapted treatment approach","volume":"31","author":"Jackson JE","year":"2009","unstructured":"Jackson JE, Dickie GJ, Wiltshire KL,  Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: toward a risk-adapted treatment approach. Head Neck 2009;31:604\u2013610."},{"key":"B110","series-title":"Cancer","first-page":"1605","article-title":"Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery","volume":"88","author":"Ratner D","year":"2000","unstructured":"Ratner D, Lowe L, Johnson TM,  Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer 2000;88:1605\u20131613."},{"key":"B111","series-title":"Am J Dermatopathol","first-page":"123","article-title":"Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma","volume":"22","author":"Brown CI","year":"2000","unstructured":"Brown CI, Perry AE. Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma. Am J Dermatopathol 2000;22:123\u2013125."},{"key":"B112","series-title":"Cancer","first-page":"1254","article-title":"Impact of radiographic findings on prognosis for skin carcinoma with clinical perineural invasion","volume":"103","author":"Galloway TJ","year":"2005","unstructured":"Galloway TJ, Morris CG, Mancuso AA,  Impact of radiographic findings on prognosis for skin carcinoma with clinical perineural invasion. Cancer 2005;103:1254\u20131257."},{"key":"B113","series-title":"Am J Clin Oncol","first-page":"248","article-title":"Impact of radiographic findings on for prognosis skin cancer with perineural invasion","volume":"38","author":"Balamucki CJ","year":"2015","unstructured":"Balamucki CJ, DeJesus R, Galloway TJ,  Impact of radiographic findings on for prognosis skin cancer with perineural invasion. Am J Clin Oncol 2015;38:248\u2013251."},{"key":"B114","series-title":"ORL J Otorhinolaryngol Relat Spec","first-page":"21","article-title":"Perineural invasion in aggressive skin carcinomas of the head and neck. Potentially dangerous but frequently overlooked","volume":"71","author":"Cernea CR","year":"2009","unstructured":"Cernea CR, Ferraz AR, de Castro IV,  Perineural invasion in aggressive skin carcinomas of the head and neck. Potentially dangerous but frequently overlooked. ORL J Otorhinolaryngol Relat Spec 2009;71:21\u201326."},{"key":"B115","series-title":"Arch Dermatol","first-page":"1663","article-title":"Aggressive-growth basal cell carcinoma in young adults","volume":"127","author":"Leffell DJ","year":"1991","unstructured":"Leffell DJ, Headington JT, Wong DS,  Aggressive-growth basal cell carcinoma in young adults. Arch Dermatol 1991;127:1663\u20131667."},{"key":"B116","series-title":"Arch Dermatol","first-page":"593","article-title":"Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes","volume":"133","author":"McCormack CJ","year":"1997","unstructured":"McCormack CJ, Kelly JW, Dorevitch AP. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes. Arch Dermatol 1997;133:593\u2013596."},{"key":"B117","series-title":"J Invest Dermatol","first-page":"880","article-title":"Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors","volume":"110","author":"Bastiaens MT","year":"1998","unstructured":"Bastiaens MT, Hoefnagel JJ, Bruijn JA,  Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol 1998;110:880\u2013884."},{"key":"B118","series-title":"Br J Dermatol","first-page":"41","article-title":"Variations of basal cell carcinomas according to gender, age, location and histopathological subtype","volume":"147","author":"Scrivener Y","year":"2002","unstructured":"Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002;147:41\u201347."},{"key":"B119","series-title":"Br J Dermatol","first-page":"401","article-title":"Basal cell carcinoma: histological classification and body-site distribution","volume":"155","author":"Raasch BA","year":"2006","unstructured":"Raasch BA, Buettner PG, Garbe C. Basal cell carcinoma: histological classification and body-site distribution. Br J Dermatol 2006;155:401\u2013407."},{"key":"B120","series-title":"J Dermatol Surg Oncol","first-page":"560","article-title":"Basal cell carcinoma treated with Mohs surgery. A comparison of 54 younger patients with 1050 older patients","volume":"18","author":"Dinehart SM","year":"1992","unstructured":"Dinehart SM, Dodge R, Stanley WE,  Basal cell carcinoma treated with Mohs surgery. A comparison of 54 younger patients with 1050 older patients. J Dermatol Surg Oncol 1992;18:560\u2013566."},{"key":"B121","series-title":"Br J Plast Surg","first-page":"393","article-title":"Aggressive basal cell carcinoma in young patients: fact or fiction?","volume":"53","author":"Milroy CJ","year":"2000","unstructured":"Milroy CJ, Horlock N, Wilson GD,  Aggressive basal cell carcinoma in young patients: fact or fiction? Br J Plast Surg 2000;53:393\u2013396."},{"key":"B122","series-title":"Dermatology","first-page":"119","article-title":"Basal cell carcinoma in young adults: not more aggressive than in older patients","volume":"199","author":"Roudier-Pujol C","year":"1999","unstructured":"Roudier-Pujol C, Auperin A, Nguyen T,  Basal cell carcinoma in young adults: not more aggressive than in older patients. Dermatology 1999;199:119\u2013123."},{"key":"B123","series-title":"J Invest Dermatol","first-page":"519","article-title":"Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction","volume":"108","author":"Lear JT","year":"1997","unstructured":"Lear JT, Smith AG, Bowers B,  Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction. J Invest Dermatol 1997;108:519\u2013522."},{"key":"B124","series-title":"Carcinogenesis","first-page":"2051","article-title":"The rate of increase in the numbers of primary sporadic basal cell carcinomas during follow up is associated with age at first presentation","volume":"23","author":"Ramachandran S","year":"2002","unstructured":"Ramachandran S, Fryer AA, Lovatt T,  The rate of increase in the numbers of primary sporadic basal cell carcinomas during follow up is associated with age at first presentation. Carcinogenesis 2002;23:2051\u20132054."},{"key":"B125","series-title":"Med Sci Monit","first-page":"MT13","article-title":"Prognostic value of computer-assisted morphological and morphometrical analysis for detecting the recurrence tendency of basal cell carcinoma","volume":"14","author":"Cheretis C","year":"2008","unstructured":"Cheretis C, Angelidou E, Dietrich F,  Prognostic value of computer-assisted morphological and morphometrical analysis for detecting the recurrence tendency of basal cell carcinoma. Med Sci Monit 2008;14:MT13\u2013MT19."},{"key":"B126","series-title":"JAMA","first-page":"3305","article-title":"Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer","volume":"267","author":"Karagas MR","year":"1992","unstructured":"Karagas MR, Stukel TA, Greenberg ER,  Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. JAMA 1992;267:3305\u20133310."},{"key":"B127","series-title":"J Am Acad Dermatol","first-page":"468","article-title":"Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors","volume":"52","author":"Lovatt TJ","year":"2005","unstructured":"Lovatt TJ, Lear JT, Bastrilles J,  Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. J Am Acad Dermatol 2005;52:468\u2013473."},{"key":"B128","series-title":"Int J Cancer","first-page":"2622","article-title":"Clinical signs of photodamage are associated with basal cell carcinoma multiplicity and site: a 16-year longitudinal study","volume":"127","author":"Richmond-Sinclair NM","year":"2010","unstructured":"Richmond-Sinclair NM, Pandeya N, Williams GM,  Clinical signs of photodamage are associated with basal cell carcinoma multiplicity and site: a 16-year longitudinal study. Int J Cancer 2010;127:2622\u20132629."},{"key":"B129","series-title":"Br J Dermatol","first-page":"874","article-title":"Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands","volume":"165","author":"Flohil SC","year":"2011","unstructured":"Flohil SC, Koljenovi\u0107 S, de Haas ER,  Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands. Br J Dermatol 2011;165:874\u2013881."},{"key":"B130","series-title":"J Invest Dermatol","first-page":"2649","article-title":"Predicting the Risk of a Second Basal Cell Carcinoma","volume":"135","author":"Verkouteren JAC","year":"2015","unstructured":"Verkouteren JAC, Smedinga H, Steyerberg EW,  Predicting the Risk of a Second Basal Cell Carcinoma. J Invest Dermatol 2015;135:2649\u20132656."},{"key":"B131","series-title":"Int J Cancer","first-page":"283","article-title":"Subsequent primary cancers after basal-cell carcinoma: a nationwide study in Finland from 1953 to 1995","volume":"87","author":"Mil\u00e1n T","year":"2000","unstructured":"Mil\u00e1n T, Pukkala E, Verkasalo PK,  Subsequent primary cancers after basal-cell carcinoma: a nationwide study in Finland from 1953 to 1995. Int J Cancer 2000;87:283\u2013288."},{"key":"B132","series-title":"Eur J Cancer","first-page":"774","article-title":"Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease","volume":"50","author":"McCusker M","year":"2014","unstructured":"McCusker M, Basset-Seguin N, Dummer R,  Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. Eur J Cancer 2014;50:774\u2013783."},{"key":"B133","series-title":"Arch Dermatol","first-page":"848","article-title":"Risk factors for single and multiple basal cell carcinomas","volume":"146","author":"Kiiski V","year":"2010","unstructured":"Kiiski V, de Vries E, Flohil SC,  Risk factors for single and multiple basal cell carcinomas. Arch Dermatol 2010;146:848\u2013855."},{"key":"B134","series-title":"J Dermatol Surg Oncol","first-page":"315","article-title":"Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up","volume":"15","author":"Rowe DE","year":"1989","unstructured":"Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15:315\u2013328."},{"key":"B135","series-title":"J Am Acad Dermatol","first-page":"1039","article-title":"Treatment of basal cell carcinoma with curettage alone","volume":"54","author":"Barlow JO","year":"2006","unstructured":"Barlow JO, Zalla MJ, Kyle A,  Treatment of basal cell carcinoma with curettage alone. J Am Acad Dermatol 2006;54:1039\u20131045."},{"key":"B136","series-title":"Arch Dermatol","first-page":"1177","article-title":"A systematic review of treatment modalities for primary basal cell carcinomas","volume":"135","author":"Thissen MR","year":"1999","unstructured":"Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999;135:1177\u20131183."},{"key":"B137","series-title":"Arch Dermatol","first-page":"540","article-title":"Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study","volume":"147","author":"Chren MM","year":"2011","unstructured":"Chren MM, Torres JS, Stuart SE,  Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study. Arch Dermatol 2011;147:540\u2013546."},{"key":"B138","series-title":"Br J Dermatol","first-page":"1407","article-title":"A comparative study of the effects of disposable and Volkmann spoon curettes in the treatment of basal cell carcinoma","volume":"161","author":"Julian C","year":"2009","unstructured":"Julian C, Bowers PW, Pritchard C. A comparative study of the effects of disposable and Volkmann spoon curettes in the treatment of basal cell carcinoma. Br J Dermatol 2009;161:1407\u20131409."},{"key":"B139","series-title":"Dermatol Surg","first-page":"719","article-title":"Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone","volume":"39","author":"Blixt E","year":"2013","unstructured":"Blixt E, Nelsen D, Stratman E. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone. Dermatol Surg 2013;39:719\u2013725."},{"key":"B140","series-title":"J Am Acad Dermatol","first-page":"91","article-title":"Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation","volume":"56","author":"Rodriguez-Vigil T","year":"2007","unstructured":"Rodriguez-Vigil T, V\u00e1zquez-L\u00f3pez F, Perez-Oliva N. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation. J Am Acad Dermatol 2007;56:91\u201395."},{"key":"B141","series-title":"Arch Dermatol","first-page":"439","article-title":"Curettage-electrodesiccation treatment of basal cell carcinomas","volume":"113","author":"Kopf AW","year":"1977","unstructured":"Kopf AW, Bart RS, Schrager D,  Curettage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol 1977;113:439\u2013443."},{"key":"B142","series-title":"J Dermatol Surg Oncol","first-page":"424","article-title":"Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma","volume":"15","author":"Rowe DE","year":"1989","unstructured":"Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989;15:424\u2013431."},{"key":"B143","series-title":"Eur J Cancer","first-page":"3011","article-title":"Surgical excision versus Mohs\u2019 micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up","volume":"50","author":"van Loo E","year":"2014","unstructured":"van Loo E, Mosterd K, Krekels GA,  Surgical excision versus Mohs\u2019 micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up. Eur J Cancer 2014;50:3011\u20133020."},{"key":"B144","series-title":"Plast Reconstr Surg","first-page":"47","article-title":"Shave excision of superficial solar skin lesions","volume":"80","author":"Emmett AJ","year":"1987","unstructured":"Emmett AJ, Broadbent GD. Shave excision of superficial solar skin lesions. Plast Reconstr Surg 1987;80:47\u201354."},{"key":"B145","series-title":"Dermatol Surg","first-page":"130","article-title":"Deep shave removal of suspected basal cell carcinoma: a prospective study","volume":"49","author":"Dando EE","year":"2023","unstructured":"Dando EE, Abban C, Shehu Wingrove A,  Deep shave removal of suspected basal cell carcinoma: a prospective study. Dermatol Surg 2023;49:130\u2013134."},{"key":"B146","series-title":"Dermatol Surg","first-page":"387","article-title":"Tangential shave removal of basal cell carcinoma","volume":"39","author":"Abramson AK","year":"2013","unstructured":"Abramson AK, Krasny MJ, Goldman GD. Tangential shave removal of basal cell carcinoma. Dermatol Surg 2013;39:387\u2013392."},{"key":"B147","series-title":"J Am Acad Dermatol","first-page":"791","article-title":"Traditional versus streamlined management of basal cell carcinoma (BCC): a cost analysis","volume":"73","author":"Wu X","year":"2015","unstructured":"Wu X, Elkin EB, Jason Chen CS,  Traditional versus streamlined management of basal cell carcinoma (BCC): a cost analysis. J Am Acad Dermatol 2015;73:791\u2013798."},{"key":"B148","series-title":"Dermatol Surg","first-page":"579","article-title":"Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma","volume":"33","author":"Kuijpers DI","year":"2007","unstructured":"Kuijpers DI, Thissen MR, Berretty PJ,  Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma. Dermatol Surg 2007;33:579\u2013587."},{"key":"B149","series-title":"Arch Dermatol","first-page":"1131","article-title":"Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma","volume":"143","author":"Rhodes LE","year":"2007","unstructured":"Rhodes LE, de Rie MA, Leifsdottir R,  Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007;143:1131\u20131136."},{"key":"B150","series-title":"Dermatology","first-page":"363","article-title":"Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up","volume":"220","author":"Wetzig T","year":"2010","unstructured":"Wetzig T, Woitek M, Eichhorn K,  Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up. Dermatology 2010;220:363\u2013369."},{"key":"B151","series-title":"JAMA Facial Plast Surg","first-page":"337","article-title":"Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery","volume":"15","author":"Schell AE","year":"2013","unstructured":"Schell AE, Russell MA, Park SS. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery. JAMA Facial Plast Surg 2013;15:337\u2013343."},{"key":"B152","series-title":"Cureus","first-page":"e9211","article-title":"Surgical margin of excision in basal cell carcinoma: a systematic review of literature","volume":"12","author":"Quazi SJ","year":"2020","unstructured":"Quazi SJ, Aslam N, Saleem H,  Surgical margin of excision in basal cell carcinoma: a systematic review of literature. Cureus 2020;12:e9211."},{"key":"B153","series-title":"Br J Plast Surg","first-page":"293","article-title":"Do plastic surgeons resect basal cell carcinomas too widely? A prospective study comparing surgical and histological margins","volume":"55","author":"Bisson MA","year":"2002","unstructured":"Bisson MA, Dunkin CS, Suvarna SK,  Do plastic surgeons resect basal cell carcinomas too widely? A prospective study comparing surgical and histological margins. Br J Plast Surg 2002;55:293\u2013297."},{"key":"B154","series-title":"Plast Reconstr Surg","first-page":"1222","article-title":"What is the best surgical margin for a basal cell carcinoma: a meta-analysis of the literature","volume":"126","author":"Gulleth Y","year":"2010","unstructured":"Gulleth Y, Goldberg N, Silverman RP,  What is the best surgical margin for a basal cell carcinoma: a meta-analysis of the literature. Plast Reconstr Surg 2010;126:1222\u20131231."},{"key":"B155","series-title":"Plast Reconstr Surg","first-page":"57","article-title":"Excision margins for nonmelanotic skin cancer","volume":"112","author":"Thomas DJ","year":"2003","unstructured":"Thomas DJ, King AR, Peat BG. Excision margins for nonmelanotic skin cancer. Plast Reconstr Surg 2003;112:57\u201363."},{"key":"B156","series-title":"Dermatol Surg","first-page":"704","article-title":"Complete margin assessment versus sectional assessment in surgically excised high-risk keratinocyte carcinomas: a systematic review and meta-analysis","volume":"48","author":"Fraga SD","year":"2022","unstructured":"Fraga SD, Besaw RJ, Murad F,  Complete margin assessment versus sectional assessment in surgically excised high-risk keratinocyte carcinomas: a systematic review and meta-analysis. Dermatol Surg 2022;48:704\u2013710."},{"key":"B157","series-title":"Plast Reconstr Surg","first-page":"1240","article-title":"Incomplete excision of basal cell carcinoma: a prospective trial","volume":"120","author":"Su SY","year":"2007","unstructured":"Su SY, Giorlando F, Ek EW,  Incomplete excision of basal cell carcinoma: a prospective trial. Plast Reconstr Surg 2007;120:1240\u20131248."},{"key":"B158","series-title":"Dermatol Surg","first-page":"1207","article-title":"Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases","volume":"33","author":"Farhi D","year":"2007","unstructured":"Farhi D, Dupin N, Palangi\u00e9 A,  Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases. Dermatol Surg 2007;33:1207\u20131214."},{"key":"B159","series-title":"J Eur Acad Dermatol Venereol","first-page":"2518","article-title":"Surgical treatment of basal cell carcinoma: a case series on factors influencing the risk of an incomplete primary excision","volume":"34","author":"Kappelin J","year":"2020","unstructured":"Kappelin J, Nielsen K, Nilsson F,  Surgical treatment of basal cell carcinoma: a case series on factors influencing the risk of an incomplete primary excision. J Eur Acad Dermatol Venereol 2020;34:2518\u20132525."},{"key":"B160","series-title":"ANZ J Surg","first-page":"219","article-title":"Incomplete excision of basal cell carcinomas: a retrospective audit","volume":"72","author":"Dieu T","year":"2002","unstructured":"Dieu T, Macleod AM. Incomplete excision of basal cell carcinomas: a retrospective audit. ANZ J Surg 2002;72:219\u2013221."},{"key":"B161","series-title":"Dermatology","first-page":"86","article-title":"Differences in rate of complete excision of basal cell carcinoma by dermatologists, plastic surgeons and general practitioners: a large cross-sectional study","volume":"234","author":"Ramdas K","year":"2018","unstructured":"Ramdas K, van Lee C, Beck S,  Differences in rate of complete excision of basal cell carcinoma by dermatologists, plastic surgeons and general practitioners: a large cross-sectional study. Dermatology 2018;234:86\u201391."},{"key":"B162","series-title":"J Am Acad Dermatol","first-page":"1118","article-title":"Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms","volume":"23","author":"Sexton M","year":"1990","unstructured":"Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990;23:1118\u20131126."},{"key":"B163","series-title":"J Plast Reconstr Aesthet Surg","first-page":"1485","article-title":"A five year review of basal cell carcinoma excisions","volume":"63","author":"Sherry KR","year":"2010","unstructured":"Sherry KR, Reid LA, Wilmshurst AD. A five year review of basal cell carcinoma excisions. J Plast Reconstr Aesthet Surg 2010;63:1485\u20131489."},{"key":"B164","series-title":"J Plast Reconstr Aesthet Surg","first-page":"41","article-title":"Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumours. Wider still and deeper?","volume":"60","author":"Griffiths RW","year":"2007","unstructured":"Griffiths RW, Suvarna SK, Stone J. Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumours. Wider still and deeper? J Plast Reconstr Aesthet Surg 2007;60:41\u201347."},{"key":"B165","series-title":"J Plast Reconstr Aesthet Surg","first-page":"652","article-title":"Basal cell carcinomata: risk factors for incomplete excision and results of re-excision","volume":"69","author":"Masud D","year":"2016","unstructured":"Masud D, Moustaki M, Staruch R,  Basal cell carcinomata: risk factors for incomplete excision and results of re-excision. J Plast Reconstr Aesthet Surg 2016;69:652\u2013656."},{"key":"B166","series-title":"J Plast Reconstr Aesthet Surg","first-page":"2057","article-title":"Risk and outcome analysis of 1832 consecutively excised basal cell carcinomas in a tertiary referral plastic surgery unit","volume":"63","author":"Malik V","year":"2010","unstructured":"Malik V, Goh KS, Leong S,  Risk and outcome analysis of 1832 consecutively excised basal cell carcinomas in a tertiary referral plastic surgery unit. J Plast Reconstr Aesthet Surg 2010;63:2057\u20132063."},{"key":"B167","series-title":"Arch Dermatol","first-page":"340","article-title":"Surgical margins for basal cell carcinoma","volume":"123","author":"Wolf DJ","year":"1987","unstructured":"Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol 1987;123:340\u2013344."},{"key":"B168","series-title":"Br J Dermatol","first-page":"1176","article-title":"Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study","volume":"180","author":"Weesie F","year":"2019","unstructured":"Weesie F, Naus NC, Vasilic D,  Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study. Br J Dermatol 2019;180:1176\u20131182."},{"key":"B169","series-title":"Ann Intern Med","first-page":"456","article-title":"Treatments of primary basal cell carcinoma of the skin: a systematic review and network meta- analysis","volume":"169","author":"Drucker AM","year":"2018","unstructured":"Drucker AM, Adam GP, Rofeberg V,  Treatments of primary basal cell carcinoma of the skin: a systematic review and network meta- analysis. Ann Intern Med 2018;169:456\u2013466."},{"key":"B170","series-title":"Acta Derm Venereol","first-page":"370","article-title":"Five-year results of Mohs\u2019 micrographic surgery for aggressive facial basal cell carcinoma in Sweden","volume":"79","author":"Wennberg AM","year":"1999","unstructured":"Wennberg AM, Lark\u00f6 O, Stenquist B. Five-year results of Mohs\u2019 micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol 1999;79:370\u2013372."},{"key":"B171","series-title":"J Eur Acad Dermatol Venereol","first-page":"838","article-title":"Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery","volume":"26","author":"Veronese F","year":"2012","unstructured":"Veronese F, Farinelli P, Zavattaro E,  Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery. J Eur Acad Dermatol Venereol 2012;26:838\u2013843."},{"key":"B172","series-title":"J Dermatolog Treat","first-page":"232","article-title":"Management of periocular basal cell carcinoma by Mohs micrographic surgery","volume":"24","author":"Litwin AS","year":"2013","unstructured":"Litwin AS, Rytina E, Ha T,  Management of periocular basal cell carcinoma by Mohs micrographic surgery. J Dermatolog Treat 2013;24:232\u2013234."},{"key":"B173","series-title":"Int J Dermatol","first-page":"1044","article-title":"Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study","volume":"55","author":"Sin CW","year":"2016","unstructured":"Sin CW, Barua A, Cook A. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study. Int J Dermatol 2016;55:1044\u20131047."},{"key":"B174","series-title":"J Am Acad Dermatol","first-page":"452","article-title":"Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up","volume":"53","author":"Leibovitch I","year":"2005","unstructured":"Leibovitch I, Huilgol SC, Selva D,  Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol 2005;53:452\u2013457."},{"key":"B175","series-title":"Ophthalmology","first-page":"631","article-title":"The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up","volume":"111","author":"Malhotra R","year":"2004","unstructured":"Malhotra R, Huilgol SC, Huynh NT,  The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology 2004;111:631\u2013636."},{"key":"B176","series-title":"Lancet Oncol","first-page":"1149","article-title":"Surgical excision versus Mohs\u2019 micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years\u2019 follow-up","volume":"9","author":"Mosterd K","year":"2008","unstructured":"Mosterd K, Krekels GA, Nieman FH,  Surgical excision versus Mohs\u2019 micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years\u2019 follow-up. Lancet Oncol 2008;9:1149\u20131156."},{"key":"B177","series-title":"Lancet","first-page":"1766","article-title":"Surgical excision vs Mohs\u2019 micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial","volume":"364","author":"Smeets NW","year":"2004","unstructured":"Smeets NW, Krekels GA, Ostertag JU,  Surgical excision vs Mohs\u2019 micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004;364:1766\u20131772."},{"key":"B178","series-title":"Dermatol Surg","first-page":"1349","article-title":"Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome","volume":"35","author":"Muller FM","year":"2009","unstructured":"Muller FM, Dawe RS, Moseley H,  Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome. Dermatol Surg 2009;35:1349\u20131354."},{"key":"B179","series-title":"Dan Med J","first-page":"A5171","article-title":"Favourable results of Mohs micrographic surgery for basal cell carcinoma","volume":"62","author":"Gniadecki R","year":"2015","unstructured":"Gniadecki R, Glud M, Mortensen K,  Favourable results of Mohs micrographic surgery for basal cell carcinoma. Dan Med J 2015;62:A5171."},{"key":"B180","series-title":"J Eur Acad Dermatol Venereol","first-page":"1228","article-title":"Mohs micrographic surgery for basal cell carcinomas: appropriateness of \u2018Rotterdam\u2019 criteria and predictive factors for three or more stages","volume":"27","author":"Flohil SC","year":"2013","unstructured":"Flohil SC, van Dorst AM, Nijsten T,  Mohs micrographic surgery for basal cell carcinomas: appropriateness of \u2018Rotterdam\u2019 criteria and predictive factors for three or more stages. J Eur Acad Dermatol Venereol 2013;27:1228\u20131235."},{"key":"B181","series-title":"Clinics (Sao Paulo)","first-page":"721","article-title":"The importance of superficial basal cell carcinoma in a retrospective study of 139 patients who underwent Mohs micrographic surgery in a Brazilian university hospital","volume":"70","author":"Takata Pontes L","year":"2015","unstructured":"Takata Pontes L, Fantelli Stelini R, Cintra ML,  The importance of superficial basal cell carcinoma in a retrospective study of 139 patients who underwent Mohs micrographic surgery in a Brazilian university hospital. Clinics (Sao Paulo) 2015;70:721\u2013725."},{"key":"B182","series-title":"Br J Ophthalmol","first-page":"474","article-title":"Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure","volume":"93","author":"Morris DS","year":"2009","unstructured":"Morris DS, Elzaridi E, Clarke L,  Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure. Br J Ophthalmol 2009;93:474\u2013476."},{"key":"B183","series-title":"Laryngoscope","first-page":"1994","article-title":"Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck","volume":"119","author":"Mendenhall WM","year":"2009","unstructured":"Mendenhall WM, Amdur RJ, Hinerman RW,  Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope 2009;119:1994\u20131999."},{"key":"B184","series-title":"Oral Oncol","first-page":"918","article-title":"Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion","volume":"48","author":"Mendenhall WM","year":"2012","unstructured":"Mendenhall WM, Ferlito A, Takes RP,  Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol 2012;48:918\u2013922."},{"key":"B185","series-title":"Cancer","first-page":"1053","article-title":"What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion?","volume":"109","author":"Han A","year":"2007","unstructured":"Han A, Ratner D. What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? Cancer 2007;109:1053\u20131059."},{"key":"B186","series-title":"Cancer","first-page":"2134","article-title":"Basal cell carcinoma treated with radiation therapy","volume":"68","author":"Wilder RB","year":"1991","unstructured":"Wilder RB, Kittelson JM, Shimm DS. Basal cell carcinoma treated with radiation therapy. Cancer 1991;68:2134\u20132137."},{"key":"B187","series-title":"Arch Dermatol","first-page":"1668","article-title":"Recurrent basal cell carcinoma treated with radiation therapy","volume":"127","author":"Wilder RB","year":"1991","unstructured":"Wilder RB, Shimm DS, Kittelson JM,  Recurrent basal cell carcinoma treated with radiation therapy. Arch Dermatol 1991;127:1668\u20131672."},{"key":"B188","series-title":"Plast Reconstr Surg","first-page":"1169","article-title":"Long-term results of irradiation for basal cell carcinoma of the skin of the nose","volume":"93","author":"Childers BJ","year":"1994","unstructured":"Childers BJ, Goldwyn RM, Ramos D,  Long-term results of irradiation for basal cell carcinoma of the skin of the nose. Plast Reconstr Surg 1994;93:1169\u20131173."},{"key":"B189","series-title":"Int J Dermatol","first-page":"453","article-title":"Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments","volume":"46","author":"Hern\u00e1ndez-Machin B","year":"2007","unstructured":"Hern\u00e1ndez-Machin B, Borrego L, Gil-Garc\u00eda M,  Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments. Int J Dermatol 2007;46:453\u2013459."},{"key":"B190","series-title":"J Dermatol Surg Oncol","first-page":"549","article-title":"Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy","volume":"18","author":"Silverman MK","year":"1992","unstructured":"Silverman MK, Kopf AW, Gladstein AH,  Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol 1992;18:549\u2013554."},{"key":"B191","series-title":"Cancer","first-page":"2708","article-title":"Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2","volume":"98","author":"Zagrodnik B","year":"2003","unstructured":"Zagrodnik B, Kempf W, Seifert B,  Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer 2003;98:2708\u20132714."},{"key":"B192","series-title":"J Am Acad Dermatol","first-page":"1235","article-title":"Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients","volume":"67","author":"Cognetta AB","year":"2012","unstructured":"Cognetta AB, Howard BM, Heaton HP,  Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients. J Am Acad Dermatol 2012;67:1235\u20131241."},{"key":"B193","series-title":"Br J Cancer","first-page":"100","article-title":"Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study","volume":"76","author":"Avril MF","year":"1997","unstructured":"Avril MF, Auperin A, Margulis A,  Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997;76:100\u2013106."},{"key":"B194","series-title":"Plast Reconstr Surg","first-page":"2544","article-title":"Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face","volume":"105","author":"Petit JY","year":"2000","unstructured":"Petit JY, Avril MF, Margulis A,  Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 2000;105:2544\u20132551."},{"key":"B195","series-title":"Clin Radiol","first-page":"33","article-title":"Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy","volume":"37","author":"Hall VL","year":"1986","unstructured":"Hall VL, Leppard BJ, McGill J,  Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 1986;37:33\u201334."},{"key":"B196","series-title":"Br J Ophthalmol","first-page":"1393","article-title":"Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma","volume":"95","author":"Garcia-Martin E","year":"2011","unstructured":"Garcia-Martin E, Gil-Arribas LM, Idoipe M,  Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma. Br J Ophthalmol 2011;95:1393\u20131396."},{"key":"B197","series-title":"Radiother Oncol","first-page":"13","article-title":"Hypofractionated radiation therapy for basal and squamous cell skin cancer: a meta-analysis","volume":"125","author":"Zaorsky NG","year":"2017","unstructured":"Zaorsky NG, Lee CT, Zhang E,  Hypofractionated radiation therapy for basal and squamous cell skin cancer: a meta-analysis. Radiother Oncol 2017;125:13\u201320."},{"key":"B198","series-title":"Br J Radiol","first-page":"608","article-title":"Use of a radon mould technique for skin cancer: results from the Peter MacCallum Cancer Institute (1975\u20131984)","volume":"62","author":"Ashby MA","year":"1989","unstructured":"Ashby MA, Pacella JA, de Groot R,  Use of a radon mould technique for skin cancer: results from the Peter MacCallum Cancer Institute (1975\u20131984). Br J Radiol 1989;62:608\u2013612."},{"key":"B199","series-title":"J Dermatolog Treat","first-page":"969","article-title":"Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study","volume":"33","author":"Cipriani C","year":"2022","unstructured":"Cipriani C, Desantis M, Dahlhoff G,  Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study. J Dermatolog Treat 2022;33:969\u2013975."},{"key":"B200","series-title":"Clin Exp Dermatol","first-page":"745","article-title":"Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinoma","volume":"33","author":"Sedda AF","year":"2008","unstructured":"Sedda AF, Rossi G, Cipriani C,  Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinoma. Clin Exp Dermatol 2008;33:745\u2013749."},{"key":"B201","series-title":"Int J Radiat Oncol Biol Phys","first-page":"e839","article-title":"Brachytherapy in lip carcinoma: long-term results","volume":"81","author":"Guibert M","year":"2011","unstructured":"Guibert M, David I, Vergez S,  Brachytherapy in lip carcinoma: long-term results. Int J Radiat Oncol Biol Phys 2011;81:e839\u2013e843."},{"key":"B202","series-title":"J Contemp Brachytherapy","first-page":"251","article-title":"Two years results of electronic brachytherapy for basal cell carcinoma","volume":"9","author":"Ballester-S\u00e1nchez R","year":"2017","unstructured":"Ballester-S\u00e1nchez R, Pons-Llanas O, Candela-Juan C,  Two years results of electronic brachytherapy for basal cell carcinoma. J Contemp Brachytherapy 2017;9:251\u2013255."},{"key":"B203","series-title":"Radiat Oncol","first-page":"87","article-title":"The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer","volume":"5","author":"Bhatnagar A","year":"2010","unstructured":"Bhatnagar A, Loper A. The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer. Radiat Oncol 2010;5:87."},{"key":"B204","series-title":"J Am Acad Dermatol","first-page":"125","article-title":"Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005","volume":"56","author":"Braathen LR","year":"2007","unstructured":"Braathen LR, Szeimies RM, Basset-Seguin N,  Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007;56:125\u2013143."},{"key":"B205","series-title":"J Invest Dermatol","first-page":"527","article-title":"Five-year results of a randomized controlled trial comparing effectiveness of photodynamic therapy, topical imiquimod, and topical 5-fluorouracil in patients with superficial basal cell carcinoma","volume":"138","author":"Jansen MHE","year":"2018","unstructured":"Jansen MHE, Mosterd K, Arits AH,  Five-year results of a randomized controlled trial comparing effectiveness of photodynamic therapy, topical imiquimod, and topical 5-fluorouracil in patients with superficial basal cell carcinoma. J Invest Dermatol 2018;138:527\u2013533."},{"key":"B206","series-title":"Dermatol Surg","first-page":"1423","article-title":"Treatment patterns, outcomes, and patient satisfaction of primary epidermally limited nonmelanoma skin cancer","volume":"43","author":"Drew BA","year":"2017","unstructured":"Drew BA, Karia PS, Mora AN,  Treatment patterns, outcomes, and patient satisfaction of primary epidermally limited nonmelanoma skin cancer. Dermatol Surg 2017;43:1423\u20131430."},{"key":"B207","series-title":"Postepy Dermatol Alergol","first-page":"88","article-title":"Clinical practice trends in cryosurgery: a retrospective study of cutaneous lesions","volume":"32","author":"Afsar FS","year":"2015","unstructured":"Afsar FS, Erkan CD, Karaca S. Clinical practice trends in cryosurgery: a retrospective study of cutaneous lesions. Postepy Dermatol Alergol 2015;32:88\u201393."},{"key":"B208","series-title":"Dermatol Surg","first-page":"318","article-title":"Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial","volume":"31","author":"Peris K","year":"2005","unstructured":"Peris K, Campione E, Micantonio T,  Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial. Dermatol Surg 2005;31:318\u2013323."},{"key":"B209","series-title":"J Am Acad Dermatol","first-page":"616","article-title":"A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma","volume":"57","author":"Eigentler TK","year":"2007","unstructured":"Eigentler TK, Kamin A, Weide BM,  A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. J Am Acad Dermatol 2007;57:616\u2013621."},{"key":"B210","series-title":"J Am Acad Dermatol","first-page":"722","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies","volume":"50","author":"Geisse J","year":"2004","unstructured":"Geisse J, Caro I, Lindholm J,  Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004;50:722\u2013733."},{"key":"B211","series-title":"Br J Dermatol","first-page":"939","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe","volume":"152","author":"Schulze HJ","year":"2005","unstructured":"Schulze HJ, Cribier B, Requena L,  Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 2005;152:939\u2013947."},{"key":"B212","series-title":"Cutis","first-page":"318","article-title":"Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study","volume":"85","author":"Quirk C","year":"2010","unstructured":"Quirk C, Gebauer K, De\u2019Ambrosis B,  Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study. Cutis 2010;85:318\u2013324."},{"key":"B213","series-title":"J Am Acad Dermatol","first-page":"807","article-title":"Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial","volume":"44","author":"Marks R","year":"2001","unstructured":"Marks R, Gebauer K, Shumack S,  Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001;44:807\u2013813."},{"key":"B214","series-title":"Eur J Dermatol","first-page":"677","article-title":"Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe","volume":"18","author":"Gollnick H","year":"2008","unstructured":"Gollnick H, Barona CG, Frank RG,  Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe. Eur J Dermatol 2008;18:677\u2013682."},{"key":"B215","series-title":"Br J Dermatol","first-page":"549","article-title":"Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC","volume":"169","author":"McKay KM","year":"2013","unstructured":"McKay KM, Sambrano BL, Fox PS,  Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC. Br J Dermatol 2013;169:549\u2013554."},{"key":"B216","series-title":"Lancet Oncol","first-page":"96","article-title":"Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial","volume":"15","author":"Bath-Hextall F","year":"2014","unstructured":"Bath-Hextall F, Ozolins M, Armstrong SJ,  Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncol 2014;15:96\u2013105."},{"key":"B217","series-title":"J Invest Dermatol","first-page":"614","article-title":"Surgery versus 5% imiquimod for nodular and superficial basal cell carcinoma: 5-year results of the SINS randomized controlled trial","volume":"137","author":"Williams HC","year":"2017","unstructured":"Williams HC, Bath-Hextall F, Ozolins M,  Surgery versus 5% imiquimod for nodular and superficial basal cell carcinoma: 5-year results of the SINS randomized controlled trial. J Invest Dermatol 2017;137:614\u2013619."},{"key":"B218","series-title":"J Am Acad Dermatol","first-page":"552","article-title":"Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): a review","volume":"74","author":"Metterle L","year":"2016","unstructured":"Metterle L, Nelson C, Patel N. Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): a review. J Am Acad Dermatol 2016;74:552\u2013557."},{"key":"B219","series-title":"J Am Acad Dermatol","first-page":"423","article-title":"Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: a retrospective cohort analysis","volume":"87","author":"Neale H","year":"2022","unstructured":"Neale H, Michelon M, Jacob S,  Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: a retrospective cohort analysis. J Am Acad Dermatol 2022;87:423\u2013425."},{"key":"B220","series-title":"Lancet Oncol","first-page":"647","article-title":"Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial","volume":"14","author":"Arits AH","year":"2013","unstructured":"Arits AH, Mosterd K, Essers BA,  Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol 2013;14:647\u2013654."},{"key":"B221","series-title":"J Invest Dermatol","first-page":"1568","article-title":"Three-year follow-up results of photodynamic therapy vs. imiquimod vs. fluorouracil for treatment of superficial basal cell carcinoma: a single-blind, noninferiority, randomized controlled trial","volume":"136","author":"Roozeboom MH","year":"2016","unstructured":"Roozeboom MH, Arits AHMM, Mosterd K,  Three-year follow-up results of photodynamic therapy vs. imiquimod vs. fluorouracil for treatment of superficial basal cell carcinoma: a single-blind, noninferiority, randomized controlled trial. J Invest Dermatol 2016;136:1568\u20131574."},{"key":"B222","series-title":"Dermatol Surg","first-page":"433","article-title":"5% 5-fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction","volume":"33","author":"Gross K","year":"2007","unstructured":"Gross K, Kircik L, Kricorian G. 5% 5-fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 2007;33:433\u2013439; discussion 440."},{"key":"B223","series-title":"Dermatologica","first-page":"368","article-title":"Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. A 10-year follow-up study","volume":"158","author":"Reymann F","year":"1979","unstructured":"Reymann F. Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. A 10-year follow-up study. Dermatologica 1979;158:368\u2013372."},{"key":"B224","series-title":"Arch Dermatol","first-page":"1431","article-title":"Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review","volume":"145","author":"Love WE","year":"2009","unstructured":"Love WE, Bernhard JD, Bordeaux JS. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol 2009;145:1431\u20131438."},{"key":"B225","series-title":"J Drugs Dermatol","first-page":"642","article-title":"Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma","volume":"5","author":"Kuijpers DI","year":"2006","unstructured":"Kuijpers DI, Thissen MR, Thissen CA,  Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. J Drugs Dermatol 2006;5:642\u2013645."},{"key":"B226","series-title":"Int J Mol Sci","first-page":"23300","article-title":"Usefulness of photodynamic therapy as a possible therapeutic alternative in the treatment of basal cell carcinoma","volume":"16","author":"Savoia P","year":"2015","unstructured":"Savoia P, Deboli T, Previgliano A,  Usefulness of photodynamic therapy as a possible therapeutic alternative in the treatment of basal cell carcinoma. Int J Mol Sci 2015;16:23300\u201323317."},{"key":"B227","series-title":"Lasers Surg Med","first-page":"417","article-title":"A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma","volume":"38","author":"Oseroff AR","year":"2006","unstructured":"Oseroff AR, Blumenson LR, Wilson BD,  A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma. Lasers Surg Med 2006;38:417\u2013426."},{"key":"B228","series-title":"Br J Dermatol","first-page":"401","article-title":"A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma","volume":"157","author":"Berroeta L","year":"2007","unstructured":"Berroeta L, Clark C, Dawe RS,  A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma. Br J Dermatol 2007;157:401\u2013403."},{"key":"B229","series-title":"J Eur Acad Dermatol Venereol","first-page":"1302","article-title":"A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8\u201320 mm), with a 12-month follow-up","volume":"22","author":"Szeimies RM","year":"2008","unstructured":"Szeimies RM, Ibbotson S, Murrell DF,  A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8\u201320 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 2008;22:1302\u20131311."},{"key":"B230","series-title":"J Am Acad Dermatol","first-page":"280","article-title":"Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up","volume":"69","author":"Roozeboom MH","year":"2013","unstructured":"Roozeboom MH, Aardoom MA, Nelemans PJ,  Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up. J Am Acad Dermatol 2013;69:280\u2013287."},{"key":"B231","series-title":"J Eur Acad Dermatol Venereol","first-page":"980","article-title":"Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma","volume":"27","author":"Cosgarea R","year":"2013","unstructured":"Cosgarea R, Susan M, Crisan M,  Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma. J Eur Acad Dermatol Venereol 2013;27:980\u2013984."},{"key":"B232","series-title":"Photodermatol Photoimmunol Photomed","first-page":"44","article-title":"Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis","volume":"31","author":"Wang H","year":"2015","unstructured":"Wang H, Xu Y, Shi J,  Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis. Photodermatol Photoimmunol Photomed 2015;31:44\u201353."},{"key":"B233","series-title":"Arch Dermatol","first-page":"17","article-title":"Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial","volume":"140","author":"Rhodes LE","year":"2004","unstructured":"Rhodes LE, de Rie M, Enstr\u00f6m Y,  Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004;140:17\u201323."},{"key":"B234","series-title":"Br J Dermatol","first-page":"1277","article-title":"Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis","volume":"179","author":"Collier NJ","year":"2018","unstructured":"Collier NJ, Haylett AK, Wong TH,  Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis. Br J Dermatol 2018;179:1277\u20131296."},{"key":"B235","series-title":"J Cosmet Dermatol","first-page":"374","article-title":"Photodynamic therapy versus surgical excision to basal cell carcinoma: meta-analysis","volume":"15","author":"Zou Y","year":"2016","unstructured":"Zou Y, Zhao Y, Yu J,  Photodynamic therapy versus surgical excision to basal cell carcinoma: meta-analysis. J Cosmet Dermatol 2016;15:374\u2013382."},{"key":"B236","series-title":"Br J Dermatol","first-page":"1242","article-title":"Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment","volume":"149","author":"Horn M","year":"2003","unstructured":"Horn M, Wolf P, Wulf HC,  Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003;149:1242\u20131249."},{"key":"B237","series-title":"Br J Dermatol","first-page":"1342","article-title":"High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study","volume":"166","author":"Christensen E","year":"2012","unstructured":"Christensen E, M\u00f8rk C, Skogvoll E. High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study. Br J Dermatol 2012;166:1342\u20131348."},{"key":"B238","series-title":"Clin Dermatol","first-page":"328","article-title":"Laser and photodynamic therapy in the management of cutaneous malignancies","volume":"19","author":"Zeitouni NC","year":"2001","unstructured":"Zeitouni NC, Shieh S, Oseroff AR. Laser and photodynamic therapy in the management of cutaneous malignancies. Clin Dermatol 2001;19:328\u2013338."},{"key":"B239","series-title":"Med Sci Monit","first-page":"PI5","article-title":"The application of Levulan-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma","volume":"18","author":"Osiecka B","year":"2012","unstructured":"Osiecka B, Jurczyszyn K, Zi\u00f3\u0142kowski P. The application of Levulan-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma. Med Sci Monit 2012;18:PI5\u2013PI9."},{"key":"B240","series-title":"Br J Dermatol","first-page":"864","article-title":"Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial","volume":"159","author":"Mosterd K","year":"2008","unstructured":"Mosterd K, Thissen MR, Nelemans P,  Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial. Br J Dermatol 2008;159:864\u2013870."},{"key":"B241","series-title":"J Eur Acad Dermatol Venereol","first-page":"896","article-title":"Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response","volume":"25","author":"Fantini F","year":"2011","unstructured":"Fantini F, Greco A, Del Giovane C,  Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response. J Eur Acad Dermatol Venereol 2011;25:896\u2013901."},{"key":"B242","series-title":"Br J Dermatol","first-page":"765","article-title":"Photodynamic therapy with topical methyl aminolaevulinate for \u2018difficult-to-treat\u2019 basal cell carcinoma","volume":"152","author":"Vinciullo C","year":"2005","unstructured":"Vinciullo C, Elliott T, Francis D,  Photodynamic therapy with topical methyl aminolaevulinate for \u2018difficult-to-treat\u2019 basal cell carcinoma. Br J Dermatol 2005;152:765\u2013772."},{"key":"B243","series-title":"J Eur Acad Dermatol Venereol","first-page":"1061","article-title":"Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities","volume":"23","author":"Sotiriou E","year":"2009","unstructured":"Sotiriou E, Apalla Z, Maliamani F,  Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities. J Eur Acad Dermatol Venereol 2009;23:1061\u20131065."},{"key":"B244","series-title":"Br J Dermatol","first-page":"1245","article-title":"Guidelines for topical photodynamic therapy: update","volume":"159","author":"Morton CA","year":"2008","unstructured":"Morton CA, McKenna KE, Rhodes LE,  Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008;159:1245\u20131266."},{"key":"B245","series-title":"Dermatol Surg","first-page":"566","article-title":"Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma","volume":"29","author":"Kokoszka A","year":"2003","unstructured":"Kokoszka A, Scheinfeld N. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatol Surg 2003;29:566\u2013571."},{"key":"B246","series-title":"J Am Acad Dermatol","first-page":"1002","article-title":"The five-year cure rate achieved by cryosurgery for skin cancer","volume":"24","author":"Kuflik EG","year":"1991","unstructured":"Kuflik EG, Gage AA. The five-year cure rate achieved by cryosurgery for skin cancer. J Am Acad Dermatol 1991;24:1002\u20131004."},{"key":"B247","series-title":"Dermatol Surg","first-page":"854","article-title":"Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules","volume":"22","author":"Mallon E","year":"1996","unstructured":"Mallon E, Dawber R. Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules. Dermatol Surg 1996;22:854\u2013858."},{"key":"B248","series-title":"Br J Dermatol","first-page":"832","article-title":"Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial","volume":"144","author":"Wang I","year":"2001","unstructured":"Wang I, Bendsoe N, Klinteberg CA,  Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001;144:832\u2013840."},{"key":"B249","series-title":"Eur J Dermatol","first-page":"547","article-title":"Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial","volume":"18","author":"Basset-Seguin N","year":"2008","unstructured":"Basset-Seguin N, Ibbotson SH, Emtestam L,  Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 2008;18:547\u2013553."},{"key":"B250","series-title":"Dermatol Surg","first-page":"759","article-title":"Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck","volume":"26","author":"Thissen MR","year":"2000","unstructured":"Thissen MR, Nieman FH, Ideler AH,  Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 2000;26:759\u2013764."},{"key":"B251","series-title":"Br J Dermatol","first-page":"733","article-title":"Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials","volume":"167","author":"Roozeboom MH","year":"2012","unstructured":"Roozeboom MH, Arits AHMM, Nelemans PJ,  Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol 2012;167:733\u2013756."},{"key":"B252","series-title":"Br J Dermatol","first-page":"739","article-title":"Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial","volume":"172","author":"Roozeboom MH","year":"2015","unstructured":"Roozeboom MH, Nelemans PJ, Mosterd K,  Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. Br J Dermatol 2015;172:739\u2013745."},{"key":"B253","series-title":"N Engl J Med","first-page":"1618","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen AC","year":"2015","unstructured":"Chen AC, Martin AJ, Choy B,  A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med 2015;373:1618\u20131626."},{"key":"B254","series-title":"Br J Dermatol","first-page":"1073","article-title":"A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients","volume":"175","author":"Chen AC","year":"2016","unstructured":"Chen AC, Martin AJ, Dalziell RA,  A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. Br J Dermatol 2016;175:1073\u20131075."},{"key":"B255","series-title":"J Invest Dermatol","first-page":"1497","article-title":"Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials","volume":"132","author":"Surjana D","year":"2012","unstructured":"Surjana D, Halliday GM, Martin AJ,  Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. J Invest Dermatol 2012;132:1497\u20131500."},{"key":"B256","series-title":"J Natl Cancer Inst","first-page":"1835","article-title":"Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial","volume":"102","author":"Elmets CA","year":"2010","unstructured":"Elmets CA, Viner JL, Pentland AP,  Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst 2010;102:1835\u20131844."},{"key":"B257","series-title":"Cancer","first-page":"2128","article-title":"Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251)","volume":"118","author":"Kadakia KC","year":"2012","unstructured":"Kadakia KC, Barton DL, Loprinzi CL,  Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251). Cancer 2012;118:2128\u20132137."},{"key":"B258","series-title":"JAMA Dermatol","first-page":"1117","article-title":"Evaluation of the use of capecitabine for the treatment and prevention of actinic keratoses, squamous cell carcinoma, and basal cell carcinoma: a systematic review","volume":"156","author":"Schauder DM","year":"2020","unstructured":"Schauder DM, Kim J, Nijhawan RI. Evaluation of the use of capecitabine for the treatment and prevention of actinic keratoses, squamous cell carcinoma, and basal cell carcinoma: a systematic review. JAMA Dermatol 2020;156:1117\u20131124."},{"key":"B259","series-title":"Cancer Prev Res (Phila)","first-page":"292","article-title":"Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome","volume":"7","author":"Tang JY","year":"2014","unstructured":"Tang JY, Chiou AS, Mackay-Wiggan JM,  Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome. Cancer Prev Res (Phila) 2014;7:292\u2013299."},{"key":"B260","year":"2023","unstructured":"Prescribing information for vismodegib capsule for oral use. 2023. Accessed September 1, 2023. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/203388s017lbl.pdf"},{"key":"B261","series-title":"N Engl J Med","first-page":"2171","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic A","year":"2012","unstructured":"Sekulic A, Migden MR, Oro AE,  Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012;366:2171\u20132179."},{"key":"B262","series-title":"J Am Acad Dermatol","first-page":"1021","article-title":"Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC","volume":"72","author":"Sekulic A","year":"2015","unstructured":"Sekulic A, Migden MR, Lewis KD,  Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. J Am Acad Dermatol 2015;72:1021\u20131026.e8."},{"key":"B263","series-title":"BMC Cancer","first-page":"332","article-title":"Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study","volume":"17","author":"Sekulic A","year":"2017","unstructured":"Sekulic A, Migden MR, Basset-Seguin N,  Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study. BMC Cancer 2017;17:332."},{"key":"B264","series-title":"Oncologist","first-page":"790","article-title":"Clinical benefit assessment of vismodegib therapy in patients with advanced basal cell carcinoma","volume":"19","author":"Dreno B","year":"2014","unstructured":"Dreno B, Basset-Seguin N, Caro I,  Clinical benefit assessment of vismodegib therapy in patients with advanced basal cell carcinoma. Oncologist 2014;19:790\u2013796."},{"key":"B265","series-title":"N Engl J Med","first-page":"2180","article-title":"Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome","volume":"366","author":"Tang JY","year":"2012","unstructured":"Tang JY, Mackay-Wiggan JM, Aszterbaum M,  Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 2012;366:2180\u20132188."},{"key":"B266","series-title":"Lancet Oncol","first-page":"1720","article-title":"Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"17","author":"Tang JY","year":"2016","unstructured":"Tang JY, Ally MS, Chanana AM,  Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol 2016;17:1720\u20131731."},{"key":"B267","series-title":"JAMA Dermatol","first-page":"542","article-title":"The use of vismodegib to shrink keratocystic odontogenic tumors in patients with basal cell nevus syndrome","volume":"150","author":"Ally MS","year":"2014","unstructured":"Ally MS, Tang JY, Joseph T,  The use of vismodegib to shrink keratocystic odontogenic tumors in patients with basal cell nevus syndrome. JAMA Dermatol 2014;150:542\u2013545."},{"key":"B268","year":"2023","unstructured":"Prescribing information for sonidegib capsules, for oral use. 2023. Accessed September 1, 2023. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/205266s009lbl.pdf"},{"key":"B269","series-title":"Lancet Oncol","first-page":"716","article-title":"Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial","volume":"16","author":"Migden MR","year":"2015","unstructured":"Migden MR, Guminski A, Gutzmer R,  Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol 2015;16:716\u2013728."},{"key":"B270","series-title":"Dermatol Ther (Heidelb)","first-page":"2225","article-title":"Effects of Sonidegib following dose reduction and treatment interruption in patients with advanced basal cell carcinoma during 42-month BOLT trial","volume":"11","author":"Lewis K","year":"2021","unstructured":"Lewis K, Dummer R, Farberg AS,  Effects of Sonidegib following dose reduction and treatment interruption in patients with advanced basal cell carcinoma during 42-month BOLT trial. Dermatol Ther (Heidelb) 2021;11:2225\u20132234."},{"key":"B271","series-title":"J Eur Acad Dermatol Venereol","first-page":"372","article-title":"Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study","volume":"32","author":"Lear JT","year":"2018","unstructured":"Lear JT, Migden MR, Lewis KD,  Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study. J Eur Acad Dermatol Venereol 2018;32:372\u2013381."},{"key":"B272","series-title":"Br J Dermatol","first-page":"1369","article-title":"Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study","volume":"182","author":"Dummer R","year":"2020","unstructured":"Dummer R, Guminksi A, Gutzmer R,  Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study. Br J Dermatol 2020;182:1369\u20131378."},{"key":"B273","series-title":"J Am Acad Dermatol","first-page":"1162","article-title":"Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: results from the final analysis of the randomized phase 2 basal cell carcinoma outcomes with LDE225 treatment (BOLT) trial at 42 months","volume":"84","author":"Dummer R","year":"2021","unstructured":"Dummer R, Lear JT, Guminski A,  Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: results from the final analysis of the randomized phase 2 basal cell carcinoma outcomes with LDE225 treatment (BOLT) trial at 42 months. J Am Acad Dermatol 2021;84:1162\u20131164."},{"key":"B274","series-title":"BMC Cancer","first-page":"1244","article-title":"Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis","volume":"21","author":"Gutzmer R","year":"2021","unstructured":"Gutzmer R, Robert C, Loquai C,  Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis. BMC Cancer 2021;21:1244."},{"key":"B275","series-title":"Clin Cancer Res","first-page":"1325","article-title":"An investigator-initiated open-label trial of sonidegib in advanced basal cell carcinoma patients resistant to vismodegib","volume":"22","author":"Danial C","year":"2016","unstructured":"Danial C, Sarin KY, Oro AE,  An investigator-initiated open-label trial of sonidegib in advanced basal cell carcinoma patients resistant to vismodegib. Clin Cancer Res 2016;22:1325\u20131329."},{"key":"B276","series-title":"J Am Acad Dermatol","first-page":"904","article-title":"An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma","volume":"71","author":"Ally MS","year":"2014","unstructured":"Ally MS, Aasi S, Wysong A,  An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma. J Am Acad Dermatol 2014;71:904\u2013911.e1."},{"key":"B277","series-title":"J Am Acad Dermatol","first-page":"99","article-title":"A phase II, multicenter, open- label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma","volume":"73","author":"Sofen H","year":"2015","unstructured":"Sofen H, Gross KG, Goldberg LH,  A phase II, multicenter, open- label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma. J Am Acad Dermatol 2015;73:99\u2013105.e1."},{"key":"B278","series-title":"J Am Acad Dermatol","first-page":"799","article-title":"Vismodegib for radiation-induced multiple basal cell carcinomas (BCCs) of the scalp","volume":"73","author":"Tauber G","year":"2015","unstructured":"Tauber G, Pavlovsky L, Fenig E,  Vismodegib for radiation-induced multiple basal cell carcinomas (BCCs) of the scalp. J Am Acad Dermatol 2015;73:799\u2013801."},{"key":"B279","series-title":"EClinicalMedicine","first-page":"100844","article-title":"Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): neoadjuvant vismodegib in locally advanced basal cell carcinoma","volume":"35","author":"Bertrand N","year":"2021","unstructured":"Bertrand N, Guerreschi P, Basset-Seguin N,  Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): neoadjuvant vismodegib in locally advanced basal cell carcinoma. EClinicalMedicine 2021;35:100844."},{"key":"B280","series-title":"Lancet Oncol","first-page":"404","article-title":"Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial","volume":"18","author":"Dr\u00e9no B","year":"2017","unstructured":"Dr\u00e9no B, Kunstfeld R, Hauschild A,  Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial. Lancet Oncol 2017;18:404\u2013412."},{"key":"B281","series-title":"Dermatol Ther (Heidelb)","first-page":"465","article-title":"Low-dose vismodegib as maintenance therapy after locally advanced basal cell carcinoma complete remission: high efficacy with minimal toxicity","volume":"10","author":"Scalvenzi M","year":"2020","unstructured":"Scalvenzi M, Cappello M, Costa C,  Low-dose vismodegib as maintenance therapy after locally advanced basal cell carcinoma complete remission: high efficacy with minimal toxicity. Dermatol Ther (Heidelb) 2020;10:465\u2013468."},{"key":"B282","series-title":"Clin Cancer Res","first-page":"2766","article-title":"Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors","volume":"19","author":"Jimeno A","year":"2013","unstructured":"Jimeno A, Weiss GJ, Miller WH Jr,  Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors. Clin Cancer Res 2013;19:2766\u20132774."},{"key":"B283","series-title":"J Clin Oncol","first-page":"745","article-title":"Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma","volume":"32","author":"Kim DJ","year":"2014","unstructured":"Kim DJ, Kim J, Spaunhurst K,  Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma. J Clin Oncol 2014;32:745\u2013751."},{"key":"B284","year":"2020","unstructured":"Prescribing information for cemiplimab-rwlc injection, for intravenous use. 2020. Accessed September 1, 2023. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761097s003lbl.pdf"},{"key":"B285","series-title":"Lancet Oncol","first-page":"848","article-title":"Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial","volume":"22","author":"Stratigos AJ","year":"2021","unstructured":"Stratigos AJ, Sekulic A, Peris K,  Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial. Lancet Oncol 2021;22:848\u2013857."},{"key":"B286","series-title":"Cancer Invest","first-page":"396","article-title":"Metastatic basal cell carcinoma: complete response to chemotherapy and associated pure red cell aplasia","volume":"24","author":"Carneiro BA","year":"2006","unstructured":"Carneiro BA, Watkin WG, Mehta UK,  Metastatic basal cell carcinoma: complete response to chemotherapy and associated pure red cell aplasia. Cancer Invest 2006;24:396\u2013400."},{"key":"B287","series-title":"ANZ J Surg","first-page":"704","article-title":"Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel","volume":"74","author":"Jefford M","year":"2004","unstructured":"Jefford M, Kiffer JD, Somers G,  Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel. ANZ J Surg 2004;74:704\u2013705."},{"key":"B288","series-title":"Cancer Treat Rev","first-page":"440","article-title":"Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer","volume":"37","author":"Ganti AK","year":"2011","unstructured":"Ganti AK, Kessinger A. Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer. Cancer Treat Rev 2011;37:440\u2013443."},{"key":"B289","series-title":"JAMA Dermatol","first-page":"615","article-title":"Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011","volume":"149","author":"Wysong A","year":"2013","unstructured":"Wysong A, Aasi SZ, Tang JY. Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. JAMA Dermatol 2013;149:615\u2013616."},{"key":"B290","series-title":"Eur J Cancer","first-page":"73","article-title":"Systemic cytotoxic therapy of basal cell carcinoma. A review of the literature","volume":"26","author":"Pfeiffer P","year":"1990","unstructured":"Pfeiffer P, Hansen O, Rose C. Systemic cytotoxic therapy of basal cell carcinoma. A review of the literature. Eur J Cancer 1990;26:73\u201377."},{"key":"B291","series-title":"Acta Oncol","first-page":"677","article-title":"Platinum-based cytotoxic therapy in basal cell carcinoma\u2014a review of the literature","volume":"35","author":"Moeholt K","year":"1996","unstructured":"Moeholt K, Aagaard H, Pfeiffer P,  Platinum-based cytotoxic therapy in basal cell carcinoma\u2014a review of the literature. Acta Oncol 1996;35:677\u2013682."},{"key":"B292","series-title":"J Clin Oncol","first-page":"342","article-title":"Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy","volume":"8","author":"Guthrie TH Jr","year":"1990","unstructured":"Guthrie TH Jr, Porubsky ES, Luxenberg MN,  Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy. J Clin Oncol 1990;8:342\u2013346."},{"key":"B293","series-title":"Cutaneous Oncology: Pathophysiology, Diagnosis, and Management","first-page":"695","article-title":"Follow-up and prevention (basal cell carcinoma)","author":"Robinson JK","year":"1998","unstructured":"Robinson JK. Follow-up and prevention (basal cell carcinoma). In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Blackwell Science; 1998:pp. 695\u2013698."},{"key":"B294","series-title":"Arch Dermatol","first-page":"1524","article-title":"Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis","volume":"136","author":"Marcil I","year":"2000","unstructured":"Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000;136:1524\u20131530."},{"key":"B295","series-title":"J Am Acad Dermatol","first-page":"247","article-title":"Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma","volume":"61","author":"Ramachandran S","year":"2009","unstructured":"Ramachandran S, Rajaratnam R, Smith AG,  Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma. J Am Acad Dermatol 2009;61:247\u2013251."},{"key":"B296","series-title":"Eur J Cancer","first-page":"2365","article-title":"Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis","volume":"49","author":"Flohil SC","year":"2013","unstructured":"Flohil SC, van der Leest RJ, Arends LR,  Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer 2013;49:2365\u20132375."}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/21\/11\/article-p1181.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/21\/11\/article-p1181.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/21\/11\/article-p1181.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T15:31:50Z","timestamp":1699371110000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/21\/11\/article-p1181.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":296,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2023.0056","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}